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1 ZUSAMMENFASSUNG 
Bakterien können in einer Vielzahl von Formen erscheinen. Manche sind 
stäbchenförmig, manche geformt wie Spiralen andere bilden Filamente oder sogar 
komplizierte pilzartige Geflechte. Formgebend ist in Bakterien vor allem die Anordnung 
ihrer Zellwand dem sogenannten Murein oder Peptidoglykan, einer rigiden polymeren 
extrazellulären Struktur. Staphylokokken sind wie bereits in ihrem Name beschrieben, 
kleine kugelförmige Bakterien, die sich in Clustern anordnen können. Trotz seiner 
vergleichsweise einfachen Form besitzt das nicht pathogene Bakterium 
Staphylococcus carnosus drei Proteine, welche in stäbchenförmigen Bakterien mit 
dem Erhalt der Zylinderform des Mureins assoziiert werden.  
Das Ziel der Arbeit war es diese sogenannten SEDS-Proteine (steht für shape 
elongation division and sporulation, also Form, Längenwachstum, Teilung und 
Sporenbildung) auf ihrer Funktion hin zu untersuchen. Von jedem der 3 in S. carnosus 
annotierten Gene (ftsW1, ftsW2, rodA) wurden Deletionsmutanten angefertigt und 
diese wurden biochemisch und morphologisch charakterisiert. Unter den getesteten 
Bedingungen, welche den Standardbedingungen im Labor entsprachen, zeigte 
lediglich die Deletion von rodA eine eindeutige phänotypische Veränderung gegenüber 
dem Wildtyp Stamm.  
Die Wachstumsrate war verändert mit einer verkürzten lag-Phase und einem 
niedrigeren Endniveau. Diese Beobachtung und die frühzeitige, spontane Lyse des 
Mutanten-Stamms ließen darauf schließen, dass es auch Veränderungen in der 
Zellwand der Mutante gegeben hat. Lichtmikroskopische Untersuchungen der Zellen 
waren genauso wie die elektronenmikroskopischen unauffällig. Erst als mit 
fluoreszenzmikroskopischen Methoden der genaue Ort der Murein-Biosynthese 
sichtbar gemacht wurde, konnten Unterschiede in Form von einer diffusen statt 
septalen Verteilung des neu synthetisierten Mureins ausgemacht werden. Dies 
bestätigte sich nochmal durch Anwenden hochauflösender Fluoreszenzmikroskopie. 
Des Weiteren wurde das Murein bzw. dessen Zusammensetzung biochemisch und 
chromatographisch untersucht. Murein besteht aus den zwei alternierenden Zucker  
N-Acetyl-Glukosamin und N-Acetyl-Muraminsäure, die ß-(1,4) glykosidisch verknüpft 
sind. Angehängt an die Muraminsäure ist eine Peptid-Kette mit 3 bis 5 Aminosäure, 
welche in S. carnosus wiederrum über eine aus 5 Glyzinen bestehende Interpeptid-
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Brücke quervernetzt sein können. Man erhält durch Verdau mit dem Enzym 
Mutanolysin und Auftrennung über einer HPLC ein typisches Muropeptid-Muster, 
welches im Falle der Mutante eindeutig zu längeren Retentionszeiten verschoben war. 
Massenspektrometrische Analysen offenbarten den Einbau der Aminosäure Serin in 
die Muropeptide der Mutante. Diese ist nicht ungewöhnlich für Bakterien, zeigt aber, 
inwiefern die Deletion die Zellen beeinflusst. Dieser Fund wurde in einem speziell Zur 
Bestätigung dieses Fundes wurden die Aminosäuren der Stammpeptide des Mureins 
mit einer eigens dafür etablierten Methode untersucht, sowie eine zweite besser 
auflösende Massenspektrometrie durchgeführt. In beiden Fällen waren die Ergebnisse 
positiv für den Einbau von Serin in das Murein der Mutante. Eine weitere Auffälligkeit 
aus der Massenspektrometrie, nämlich das vermehrte Vorkommen von Tripeptiden, 
Mureinuntereinheiten mit lediglich drei Aminosäuren im Stammpeptid, und deren 
Abwesenheit in der Mutante führte zu dem Schluss, dass die Modifikation, die im Wild 
typ S. carnosus TM300 noch durchgeführt werden kann, in der rodA Deletion gestört 
ist. Das Enzym, das vermutlich für diese Modifikation verantwortlich ist, nennt man L, 
D-Carboxypeptidase und ist nur für zwei Staphylokokken Spezies annotiert, neben S. 
carnosus auch noch in S. pseudointermidies. Dies erklärt zum einem den Unterschied 
im Murein-Muster von S. aureus SA113 WT, der dieses Enzym nicht besitzt, zu S. 
carnosus TM300 zum anderen scheint in der rodA Deletion die Funktion des Enzyms 
beeinträchtigt zu sein, sei es durch den vermehrten Einbau von Serin, durch eine 
fehlende Aktivierung durch RodA oder durch fehlerhafte Lokalisation.  
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2 SUMMARY 
 
Bacteria can appear in various shapes. Some are rod-shaped some form spirals and 
other build filaments or even complex mycelium. The cell wall is responsible for the 
determination of the shape. The cell wall consists of peptidoglycan, which is an 
extracellular polymeric structure. Staphylococci are small spherical bacteria, which are 
known to form clusters. Despite maintaining this relatively simple form the non 
pathogenic S. carnosus possesses three so called SEDS proteins (shape, elongation, 
division and sporulation) usually associated with the rod from of other bacteria. 
The aim of this study was the estimation of all the three annotated genes (ftsW1, ftsW2, 
rodA) by creating deletions of these genes and by characterization of the deletion 
mutants. But under normal laboratory conditions only the ∆rodA deletion showed an 
obvious phenotype compared to the wild type. The growth rate was diminished but the 
lag-phase was also reduced. Regarding these results and a higher and earlier lysis 
rate in the ∆rodA deletion it was concluded that there were some alterations in the 
peptidoglycan of the mutant. Differences could not be observed in light or electron 
microscopy. However after labeling the sites of peptidoglycan biosynthesis with 
fluorescence markers, it occurred that the much defined localization of the 
peptidoglycan biosynthesis was disperse in the ∆rodA deletion. This could also be 
confirmed with super resolution fluorescence microscopy. 
Experiments regarding the composition of the peptidoglycan were performed. Usually 
in staphylococci it consists of alternating residues of β-(1,4) linked  
N-acetylglucosamine and N-acetylmuramic acid. Attached to the N-acetylmuramic acid 
is a peptide chain of three to five amino acids. The glycan chains can be crosslinked 
by the interpeptide bridge containing of 5 glycine residues. Purification, digestion with 
the enzyme mutanolysine and separation via HPLC leads to a unique pattern of 
muropeptides. This pattern was shifted to higher retention times for the mutant and 
therefore the muropeptides were analyzed in detail by mass spectrometry.  This 
revealed the incorporation of serine in the peptidoglycan of the mutant. Serine is not 
very unlikely to be found in the peptidoglycan, but unusual to result of a gene deletion. 
To confirm the serine incorporation the amino acids of the stem peptide were analyzed 
and a second MS analysis with a better resolution was performed. Both experiments 
gave positive results for serine in the mutant muropeptides. From the MS data there 
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was an interesting finding in the amount of tripeptides for the monomeric muropeptides 
of the S. carnosus TM300 WT to the penta- or tetrapeptides of the ∆rodA deletion. On 
the one hand this could explain the differences of the muropeptide pattern from  
S. aureus SA113 WT to S. carnosus TM300 WT, because there is an enzyme called 
L, D- carboxypepidase which specifically catalyzes the hydrolization of tetra- to 
tripeptides and can only be found in two of the annotated staphylococcal species, on 
the other hand the shifted muropeptide pattern of the mutant can be explained from 
the disfunction of this enzyme. The absence of RodA somehow reduces the L, D- 
carboxypepidase whether increased amount of serine turns the muropetides into a 
poor substrate for the enzyme or the RodA protein is needed for activation or correct 
localization of the L, D- carboxypepidase. 
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3 INTRODUCTION 
3.1 GENUS STAPHYLOCOCCI  
The genus Staphylococcus (Firmicutes; Bacilli, Bacillales, Staphylococcaceae) 
belongs to the Gram positive bacteria and are round shaped microorganisms, which 
often form groups of masses, hence their name: staphyle is ancient Greek for bunch 
of grapes and coccus is ancient Greek for round (Ogston, 1882). The facultative 
anaerobic, non-motile, and non sporeforming staphylococci have a low DNA G+C 
content (30-39 %) and a genome size of 2-3 Mbp in average (George, 1994; Kloos, 
1998). Around 50 species and subspecies of this genus are described and classified 
into two groups: coagulase-negative (CNS) and coagulase-positive staphylococci 
(CPS) (Rosenstein and Götz, 2013). This classification is based on the enzyme 
coagulase which is secreted and leads to agglutination of blood plasma (Tobin et al., 
1994). Most important staphylococcal species were grouped based on DNA-DNA 
hybridization studies (Schleifer et al., 1983; Münch, G. et al., 2012)  to the CNS and 
novobiocin-sensitive species groups S. epidermidis (e. g. S. lugdunensis, S. capitis, 
S. epidermidis, S. haemolyticus, S. hominis, S. warneri) and S. simulans (e. g.  
S. carnosus and S. simulans), the CNS and novobiocin-resistant species groups 
S. saprophyticus (e. g. S. cohnii, S. saprophyticus, S. xylosus) and S. sciuri, as well as 
the CPS and novobiocinsusceptible species groups S. intermedius (e. g. S. delphinii, 
S. intermedius, S. hyicus) and their main representative S. aureus (Futatsugi et al., 
2013). This mapping is backed up by analysis of the major autolysines (Albrecht, 
2012). 
Staphylococci are a wide spread species. The natural habitats of staphylococci are the 
skin, cutaneous glands and the mucosa of animals and humans. The micro flora of 
human skin is mainly composed of CNS, where S. epidermidis occurs as the most 
frequent and dominant colonizing species (Lleo et al., 1990; Marples, 1998). CNS were 
classified over a long time as saprophytic and rarely pathogenic organisms. In the 
meantime S. epidermidis, S. haemolyticus and S. saprophyticus were classified as 
opportunistic pathogens and are one of the main causes of nosocomial, foreign object 
associated, and blood stream infections especially in immunosuppressed persons 
(Tobin et al., 1994; von Eiff et al., 1997; Zell et al., 2008). In contrast to CNS, the CPS 
S. aureus strains are the major human pathogens that cause acute and inflammatory 
diseases. These are for example skin infections and invasive infections like 
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endocarditis, osteomylitis, pneumonia and sepsis. Furthermore, some S. aureus 
strains can lead to food poisonings, exfoliative dermatitis or toxic shock syndrome if 
producing the matching toxins. The main reasons for the pathogenicity of S. aureus 
are the various virulence factors such as extracellular enzymes (coagulase, DNase, 
fibrinolysin, hyaluronidase), exotoxines (α-, β-, γ-, δ-hemolysine, leukocidine, 
exfoliative toxin A and B, toxic-shock-syndrom-toxine-1), pyrogentic and 
superantigenes. Cell wall anchored surface proteins play an important role in tissue 
adhesion and immune evasion, and are also known as microbial surface components 
recognizing adhesive macromolecules (MSCRAMMs), e. g. protein A (SPA), 
fibrinogen-binding clumping factors ClfA/B; fibronectin-binding proteins FnbpA/B, or 
collagen adhesin Cna (Yokoe et al., 2014). S. aureus also has the ability to proliferate 
extracellularly, as well as intracellularly.  
In the past years, caused by an intensive use of antibiotic treatment in medical health 
care as well as livestock breeding, there was an increase in the number of antibiotic 
resistant staphylococci. This is a severe problem which is still growing and challenging 
for medical health care systems worldwide. Also an increase of antibiotic resistant CNS 
strains isolated from food was noticed (Heroven et al., 2012). CNS, such as  
S. carnosus or S. xylosus, are used as food grade organisms, e. g. as meat starter 
cultures in food industry (Hammes and Hertel, 1998; Kengara et al., 2013) . 
 
3.2 STAPHYLOCOCCUS CARNOSUS 
The species Staphylococcus carnosus was first isolated from raw meat and was 
named according to that. The coagulase negative staphylococcus (CNS) S. carnosus 
is an avirulent GRAS (generally regarded as safe) organism, which is widely used in 
food industry as meat starter culture or in biotechnology as cloning host. The natural 
habitat of S. carnosus is not known but it is speculated to be found on animal skin since 
it can be isolated from meat products or even fermented fish (Rosenstein and Götz, 
2010). 
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The genome of S. carnosus TM300 has just recently been sequenced. It revealed a 
G+C content of 34.6% which is higher than the GC content of most other 
staphylococcal species like the pathogenic S. aureus, S. epidermidis, S. saprophyticus 
and S. haemolyticus but still in the low GC-cluster of the gram-positive bacteria. In 
addition the genome with its 2,56 Mbp and only 2474 open reading frames (ORF) is 
one of the smaller staphylococcal genomes. In contrast to the pathogenic 
staphylococci, the genome contains only one prophage (ΦTM300), but no mobile 
elements such as plasmids, insertion elements or transposons are present. 55 ORFs 
of S. carnosus TM300 are disrupted, which this species might afford because of the 
nutrient rich habitat. Two out of these disrupted genes are annotated as the global 
regulators agrC and saeR (Augustin et al., 1992). Agr (accessory gene regulator) and 
SaeR are responsible for the expression of exoproteins among other main virulence 
factors (Giraudo, 1999; Rogasch et al., 2006; Prufer et al., 2012; Schonberger et al., 
2012). Another disrupted gene is ffh which encodes a key protein for signal recognition 
(Munch et al., 2012) and translocation of membrane proteins and secreted proteins to 
the cytoplasmic membrane that in B. subtilis is required for the "bacterial signal 
recognition particle" (SRP)-dependant pathway (Zanen et al., 2006). The inactivation 
of thoses three genes might explain the small amount of extracellular proteins in S. 
carnosus TM300. On the other hand the genome encodes all necessary genes for 
dissimilatoric nitrate and nitrite reduction, two genes for catalases, which are suitable 
for hydrogen peroxide reduction (Schlag, S. et al., 2008). 
To meet the requirements for a starter culture S. carnosus has to survive in a high salt 
environment and therefore possesses various osmoprotective systems and sodium-
proton-antiporter. Additionally the genome analysis revealed a gene for the ornithin-
decarboxylase, an enzyme synthesizing the biogenetic amines putrescine and 
cadaverine out of e.g. meat. These substances are natural metabolic products and 
synthetic precursors for alkaloides and polyamines as well as parts of ribosomes but 
toxic in larger amounts. Genes which are not present in S. carnosus are the ica-genes 
and so it cannot perform the PIA dependent biofilm formation. Despite of having three 
putative hemolysis and two exotoxine genes there is no hemolysis activity detectable 
in S. carnosus (Rosenstein et al., 2009) 
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3.2.1 S. CARNOSUS AS EXPRESSION SYSTEM 
 
In biotechnology it is common to produce peptides and proteins in microorganisms. 
Many recombinant proteins are produced in the Gram-negative organism Escherichia 
coli. But occasionally the overproduction in E. coli leads from misfolding to aggregation 
known as inclusion bodies (Müller et al., 2012; Siemens et al., 2012); Furthermore, 
part of the outer membrane of E. coli the lipopolysaccharide or endotoxine can cause 
severe problems, if the protein product is contaminated. Even small amounts of 
endotoxine can lead to inflammatory reactions in animal and human patients and the 
so called endotoxic shock can cause severe tissue damage or might even be lethal 
(Anspach, 2001; Ogikubo et al., 2004; Boddy et al., 2012). 
Gram-positive bacteria are a good alternative to be used as overexpression systems 
as they lack the endotoxin. Another advantage of their usage is the structure of the cell 
envelope with only an inner cytoplasmic membrane and a thick murein layer, which 
allows the secretion of proteins directly to the supernatant. In contrast, Gram-negative 
bacteria possess two membranes that secreted proteins have to pass. Bacillus subtilis 
is often used as an expression system. However, fast degradation of secreted proteins 
by exoproteases is one major disadvantage and is making the system unsuitable for 
the overproduction and secretion of proteins. Nevertheless, protease free B. subtilis 
strains are available which are used in biotechnology. In previous studies, only low 
exoproteolytic activity was observed in S. carnosus TM300 (Götz, F. et al., 1985; Liebl 
and Götz, 1986; Meens et al., 1997). This might be due to the missing or defect 
regulators for exoproteins, such as AgrC, SaeR and Ffh (Rosenstein et al., 2009). In 
contrast to the pathogenic staphylococci, no virulence factors are present in  
S. carnosus, neither secreted nor anchored to the cell wall peptidoglycan. Therefore, 
S. carnosus can serve as a system for the secretion and overproduction of proteins.  
In addition S. carnosus only possesses a small amount of IgG binding proteins unlike 
S. aureus with huge amounts of Protein A. This finding means less trouble with all 
immunological based experiments such as immune-precipitation, western blots and 
many more frequently used in research. Another advantage of working with  
S. carnosus is the consistent development of expression systems for the induction of 
gene expression, the secretion of proteins and the secretion and anchoring of proteins 
to its cell wall (Wieland et al., 1995; Peschel et al., 1996; Strauss and Gotz, 1996; 
Hansson et al., 2002; Wernerus et al., 2003; Krismer et al., 2012).To accelerate 
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complicated cloning, shuttle plasmids are available that can be used in both, E. coli 
and staphylococci (Brückner et al., 1993; Wernerus et al., 2003; Corrigan and Foster, 
2009; Arnold et al., 2012; Jarius et al., 2012; Munch et al., 2012). 
 
3.3 THE CELL WALL OF STAPHYLOCOCCI 
The murein or peptidoglycan (PG) sacculus is the shape and structure giving element 
of the bacterial cell, which in the case of the well-studied S. aureus is composed of a 
thick murein layer (~40 layers, 20-80 nm), covalently anchored and attached proteins 
as well as wall teichoic acids (WTA) (Strecker et al., 2012). The chemical composition 
of peptidoglycan is well known. It is composed of glycan chains made of polymeric 
disaccharides (N-acetylmuramic acid- (β, 1-4) -N-acetylglucosamine (MurNAc -
GlcNAc))  residues that are connected by short peptides (Weidel and Pelzer, 1964; 
Lohmann et al., 2012). The D-lactyl moiety of MurNAc is amide-linked to a 
pentapeptide that is composed of L-alanine, D-glutamic acid, L-lysine and 
D-alanine-D-alanine. There are several possible modifications like the amidation 
(Figueiredo et al., 2012; Münch, D. et al., 2012) of the D-glutamic acid or O-acetylation 
of MurNAc in pathogens (Endl et al., 1983; Bera et al., 2006). 
Two or more peptides protruding from neighboring glycan chains can be connected to 
form dimeric or multimeric crosslinks. These peptides are crosslinked by interpeptide 
bridges, which consist predominantly of pentaglycine (Gly5), and interlink between L-
lysine at position 3 and D-alanine at position four of the neighboring peptides of another 
glycan strand. This generates a three dimensional network that surrounds the cell 
(Groppa et al., 2012; Kengara et al., 2013). In S. aureus crosslinking occurs at about 
80-95% of PG subunits. 
Furthermore proteins are covalently anchored to the pentaglycine bridge by a special 
sorting system known as the sortase (Weidenmaier and Peschel, 2008). In S. aureus 
two sortases are present. The constitutively produced staphylococcal surface protein 
sortase A (SrtA) anchors all proteins containing the “LPXTG“ motif (Schleifer et al., 
1983; Mazmanian et al., 1999), whereas SrtB recognizes the cell wall sorting sequence 
“NPQTN“ and is only expressed under iron depleting conditions, e. g. during host 
infection (Marraffini et al., 2006; Yokoe et al., 2014). 
Another component of the cell wall is the peptidoglycan anchored wall teichoic acid 
(WTA). It ts covalently bound by a phosphodiester bound to the OH group at position 
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C6 of MurNAc by a GlcNAc residue (Begg and Donachie, 1985; Weidenmaier et al., 
2008; Gibson, 2009). The anchor structure consists of N-acetyl D-mannosamine 
(ManNAc), GlcNAc and two molecules of glycerol phosphate (GP). The main 
constituent of S. aureus WTA is ribitol phosphate (RboP), which consists of about 40 
repeating units. This zwitterionic polymer has negatively charged phosphate groups 
and is later D-alanylated introducing positively charged amino groups (Endl et al., 
1983; Weidenmaier et al., 2008) whereas S. carnosus WTA probably is composed of 
polyglycerol phosphate (GroP) repeating units (Kengara et al., 2013). Nevertheless, 
only 7.7% of MurNAc is phosphorylated suggesting that every thirteenth MurNAc is 
substituted by WTA. 
In pathogenic staphylococci, such as S. aureus, every second MurNAc is modified by 
O-acetylation at C-6 atom, producing the 2,6-NO diacetylmuramic acid derivative  
(Bera et al., 2006). The modification is carried out by an O-acetyl transferase (OatA) 
leading to a lysozyme resistant phenotype (Bera et al., 2005).  
Other components that interact but are not covalently bound to the PG are cell wall 
associated proteins, such as cell wall hydrolases and major autolysins. Furthermore, 
cell wall spanning molecules, such as lipoproteins (LPPs) and lipoteichoic acids (LTA) 
are attached to the cytoplasmic membrane (Heilmann et al., 1997; Stoll et al., 2005; 
Biswas et al., 2006; F. Götz, 2006). 
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3.3.1 PEPTIDOGLYCAN BIOSYNTHESIS 
 
The biosynthesis of peptidoglycan occurs in four steps. An overview is given in Figure 
1. It starts in the cytoplasm with the synthesis of the nucleotide-activated precursors 
UDP-GlcNAc and UDP-MurNAc. The latter is synthesized from UDPGlcNAc by the 
enzymes MurA and MurB. The stepwise ligation of the amino acid L-Ala, D-Glu, L-Lys, 
and D-Ala-D-Ala to UDP-MurNAc is catalyzed by the enzymes MurC, MurD, MurE, and 
MurF, respectivley (Barreteau et al., 2008). D-amino acids are converted from the L-
enantiomers by racemases. During the ligation reaction the D-Ala-D-Ala dipeptide is 
formed by Ddl A and B. The 2nd steps are located at the cytoplasmic membrane or 
more precise at its inner leaflet. MraY forms the so called Lipid I by transferation of 
MurNAc pentapeptide to undecaprenylpyrophosphate and then the 
glycosyltransferase MurG transfers a GlcNAc residue from UDP-GlcNAc to lipid I, 
gaining undecaprenyl-pyrophosphoryl- MurNAc pentapeptide-GlcNAc, the precursor 
Lipid II. The sequential synthesis of the interpeptide bridge is mediated by the non-
ribosomal peptidyltransferases of the Fem (factors essential for methicillin resistance) 
AB family (Schneider et al., 2004). Their substrate is either Lipid II or the soluble UDP-
MurNAc pentapeptide. 
Lipid II is then translocated from the inner to the outer leaflet of the cytoplasmic 
membrane by the proposed flippases FtsW or RodA (3.4). On the outside Lipid II is 
accessible by the glycosyltransferases (GTase) and transpeptidases (TPase) in form 
of various Penicillin binding proteins (PBPs) or monofunctional GTases. The GTases 
use Lipid II as substrate of the glycosyltransferase reactions to polymerize new glycan 
strands (Step III). Biochemical data and crystal structures indicate that GTases act 
processively. Lipid II is the acceptor and the glycan strand is the donor in this reaction, 
which releases the undecaprenol pyrophosphate moiety from the growing glycan 
strand (Perlstein et al., 2010). The peptide moieties from different glycan strands are 
crosslinked by transpeptidase reactions to produce the peptidoglycan polymer 
(Sauvage et al., 2008). The pentapeptide is the donor and a tri-, tetra-, or pentapeptide 
is the acceptor for this transpeptidase reaction. Finally this results in an indirect 
crosslinking between Lys of the acceptor and D-Ala at position 4 of the donor mediated 
by the interpeptide bridge. The energy used to from this crosslink comes from the 
solved peptide bond of the terminal D-Ala which is then released. 
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Figure 1: Pathway of peptidoglycan synthesis in S. aureus   
(I) The assembly of the lipid II precursor is universal for eubacteria; the MurA reaction is the 
first step committed to peptidoglycan synthesis. (II) The interpeptide is synthesized on the 
membrane-bound precursor. (III) Extracellular steps catalyzed by transglycosylases and 
transpeptidases (PBPs) lead to mature peptidoglycan (Pinho et al., 2013).  
 
3.3.2 PEPTIDOGLYCAN HYDROLYSATION 
 
Peptidoglycan hydrolases (MurNAc-l-alanine amidases, DD-endopeptidases and lytic 
transglycosylases), play important roles during growth, cell separation, and cell wall 
turnover (Gilpin et al., 1974; Wong et al., 1974). In E. coli the soluble peptidoglycan 
turnover products are transported into the cytoplasm where they are recycled for de 
novo peptidoglycan synthesis (Park and Uehara, 2008). Not much is known in Gram 
positive bacteria, but recycling is under investigation (Reith and Mayer, 2011). The 
hydrolases target different structures of the cell wall. Cleavage of the sugar backbone 
occurs specifically by muramidases, such as lysozyme, mutanolysin, or 
glucosaminidases. Within the stempeptide amidases cleave between N-acetylmuramic 
acid and L-alanine. The interpeptide bridge is targeted by endopeptidases such as 
lysostaphin, which cleaves mainly between the glycines on position 2 and 3 as well as 
position 3 and 4 (Thumm and Götz, 1997; Kull, 2009). 
I
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Figure 2: Peptidoglycan hydrolases and their site of cleavage.  
Different muropeptide cleaving enzymes and their target sites are shown in this picture. 
 
The muramidase lysozyme plays an important role in the host defense by innate 
immunity. It is a component of neutrophile granules and the major secretory product of 
macrophages. However, the earlier mentioned O-acytylation works as a resistance 
mechanism for S. aureus (Bera et al., 2005; Bera et al., 2006). The muramidases 
mutanolysin or chalaropsis muramidase derived from Streptomyces spec. can access 
and cleave the peptidoglycan sugar backbone of S. aureus (Hash, 1967; Yokogawa, 
1974).The species S. carnosus TM300 has no oatA homolog and the MurNAc is not 
O-acetylated, hence the peptidoglycan is lysozyme susceptible (Bera et al., 2006).  
The major autolysin (Atl) plays an important role during cell separation in staphylococci. 
This is a bifunctional protein, which contains an N-terminal N-acetylmuramyl-L-alanine 
amidase (AM) domain and a C-terminal N-acetylglucosaminidase (GL) domain. AtlE 
was the first major autolysin described in S. epidermidis (Oshida et al., 1995; Heilmann 
et al., 1997). In S. aureus (Baba and Schneewind, 1998; Biswas et al., 2006; Schlag, 
M. et al., 2010) and in S. carnosus (Schumacher, 2008; Costa, 2009) AtlA and Bph are 
homologous proteins respectively. S. aureus cells lacking atl form big clusters and 
were unable to divide properly (Sugai et al., 1995; Heilmann et al., 1997; Biswas et al., 
2006).  
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3.4 SEDS PROTEINS 
SEDS stands for shape, elongation, division, and sporulation. These proteins belong 
to a family of integral membrane proteins that are present in all cell wall-containing 
bacteria (Ikeda et al., 1989) and are highly conserved. In many organisms these 
proteins are essential and the elucidation of their mode of action by loss of function 
analysis cannot be done. RodA and FtsW are generally regarded as involved in the 
translocation of lipid II during cell elongation and cell division, respectively 
(Mohammadi et al., 2011). In Bacillus subtilis the depletion of rodA leads to a block in 
elongation cell growth (Henriques et al., 1998) but in E. coli RodA is not strictly 
essential for cell viability. Mutants lacking this SEDS protein show a slow growth and 
small cell diameters but are viable in minimal medium (Begg and Donachie, 1985; 
Cava et al., 2013). In addition, temperature-sensitive E. coli ftsW mutations lead to 
blocks at both early and late stages of cell division, suggesting that FtsW acts during 
both initiation and septum maturation (Perez-Nunez et al., 2011). For E. coli it is 
proposed that RodA is part of the elongation complex and FtsW functions as part of 
essential division complexes for PG synthesis. Each complex is thought to include one 
protein from the SEDS family and at least one PBP although several PBPs may 
associate with a single SEDS protein (Typas et al., 2012). Mutations in E. coli ftsI 
(encoding PBP3) that reduce the ability to divide can be suppressed by rodA mutations 
that, by themselves, interfere with normal cell growth (Begg et al., 1986). There exists 
a subset of SEDS proteins that are not essential: SpoVE is responsible for heat 
resistance of spores in B. subtilis (Real et al., 2008) and its loss does not influence the 
viability of the vegetative cells. FtsW of Steptomyces coelicolor is only needed during 
nonessential sporulation for septation and Z-ring stabilization but its deletion does not 
affect cross wall formation in vegetative hyphae (Mistry et al., 2008). Its gene ftsW was 
just recently shown to be activated by the transcriptional regulator WhiA (Matthew J. 
Busha et al., 2013). In Corynebacterium glutamicum RodA is solely localized to the 
apical pole, where cell growth takes place. Interestingly, deletion of rodA is tolerated 
but the cells grow slower and have a smaller and shorter morphology than the wild 
type cells (Sieger 2013). However, all these data come from rod-shaped bacteria, but 
so far there are no SEDS deletion mutants in bacteria that do not perform elongation 
or apical extension. 
S. carnosus is the only sequenced Staphylococcus strain that possess three genes 
annotated to encode proteins of the SEDS family: ftsW1 (Sca_0739), ftsW2 
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(Sca_1886), and rodA (Sca_1584). All other strains contain only one copy of the ftsW 
gene and one of rodA. Since it has never been observed that bacteria of this genus 
grow in other shapes then cocci, they do not perform elongational growth and therefore 
there is no discrimination between an elongasome and a divisiome. In rod shaped 
bacteria the SEDS proteins FtsW and RodA play their distinct role in either one of the 
peptidoglycan biosynthesizing machineries. The question occurs why two or even 
three SEDS proteins are needed in staphylococcal bacteria. The divison pattern of 
dividing in a 90° angle might be the answer (Turner et al., 2010). Somehow the 
localization of the division plane has to be regulated and at least one flippase has to 
be present at the new division sites. One could envision that the three SEDS proteins 
take turns to define the new division plane. 
 
3.4.1 RODA 
 
SEDS proteins and PBPs are co-localized in the genome of several bacteria but not in 
staphylococci. The rodA gene of S. carnosus is an orphan and annotated as Sca_1584. 
It is 1226 bp in size and neighbors on the upstream side a two gene operon of the D-
alanine-D-alanine ligase and the UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-
alanine ligase Sca_1583 and Sca_1582 respectively (Figure 9). On the downstream 
side is a putative copper-transporting P-type ATPase located. RodA´s orientation is 
contrary to almost all genes in this region with the exception of Sca_1589 and 
Sca_1590 a putative cardiolipin synthetase and a hypothetical protein respectively, 
which build an operon downstream of rodA.  
The gene product of rodA is a membrane protein with 405 amino acids. They form a 
structure of ten transmembrane helices (TMH). Computal analysis revealed that the C 
as well as the N-terminus is located in the cytoplasma. For the Bacillus homologue this 
was confirmed experimentally (Real et al., 2008). An over 60 amino acids long 
extracellular loop forms between TMH 7 and TMH 8. Smaller loops with approximately 
20 animo acids in size are located between TMH 3 and TMH 4 on the outside and TMH 
8 and TMH 9 on the inside of the cytoplasmic membrane as predicted by SOSUI and 
confirmded by Quick 2D. Special motives other than the high similarity to proteins of 
the SEDS family could not be recognized.  
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Even though membrane topology was determined for SpoVE of B. subtilis it was not 
possible to identify functional region within this protein (Real et al., 2008). Recently it 
was shown that the predicted transmembrane helix 4 is required for the flipping activity 
especially the two charged residues R145 and K153. Furthermore there is size 
exclusion for the transport which can be hindered by a Lipid II variant increased by 420 
Da. This leads to the assumption of a pore like mechanism for the FstW of E. coli 
(Mohammadi et al., 2014). 
 
Figure 3: Topology model of RodA  
Model created with predictions of SOSUI. 
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4 METHODS AND MATERIALS  
4.1 ABBREVIATIONS 
 
A     Ampere 
Ala     Alanine 
Ami     Amidase 
APS     Ammoniumpersulfate 
B.     Bacillus 
BHI     Brain Heart Infusion 
bidest     double destilled 
BM     Basic Medium 
bp     Basepairs 
BSA     bovine serumalbumine 
C-terminal    Carboxy terminal 
C-Terminus    Carboxy terminus 
cat     Chloramphenicolacetyltransferase 
CHAP cystein-,histidindependent 
amidohydrolases/peptidases 
CW Cell wall 
DA     Diaminoacids 
DAPI     4',6-diamidino-2-phenylindole 
DNA     Desoxyribonucleine acid 
E. coli     Escherichia coli 
EDTA     Ethylendiamintetraacetat 
EtOH     Ethanol 
ERT     Eppendorf reaction tube 
g     Gramm 
gen.     genomic 
GFP     green fluorescence protein 
GlcNAc    N-Acetylglucosamine 
Glu     Glutamic acid 
Gly     Glycine 
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His     Histidine 
HPLC     high performance liquid chromatography 
k     Kilo- 
kan     Kanamycin 
kb     Kilobasepairs 
kDa     Kilodalton 
KO     Knock-out 
l     Liter 
LB     Luria Bertani 
Lys     Lysine 
LysM     Lysine motif 
m     Milli- 
M     Molar (= mol per liter) 
mA     Milliampere 
min     Minute 
ml     Milliliter 
mM     Millimolar 
MRSA    Methicillin/Multi-resistent Staphylococcus aureus 
MS     Mass spectrometry 
MurNAc    N-Acetylmuramic acid 
Mut     Mutanolysine 
Ni     Nickel 
N-terminal    Amino terminal 
N-Terminus    Amino terminus 
nm     Nanometer 
OD     Optical density 
ONC     Overnight culture 
p     Pico- 
PALM     Photoactivated Localization Microscopy 
PAGE     Polyacrylamidgelelectrophoresis 
PBP     Penicillinbinding protein 
PCR     Polymerase chain reaction 
PG     Peptidoglycan 
Ppm     Parts per million 
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rpm     rounds per minute 
REM     Raster electron microscopy 
S.     Staphylococcus 
Sca     Staphylococcus carnosus 
SDS     Sodiumdodecylsulfat 
SEDS     shape, elongation, division and sporulation 
SfGFP    superfolder green fluorescent protein 
STROM    Stochastic Optical Reconstruction Microscopy 
SP     Signalpeptide 
TAT     Twin-Arginin Transport 
TEMED    Tetramethylethylenediamine 
TM°     melting temperature 
Tris     Tris(hydroxymethyl)aminomethan 
u     units 
UDP     Uridindyl phosphate 
V     Volt 
VRSA     Vancomycin-resistenter Staphylococcus aureus 
 
4.2 AMINO ACID CODE 
 
A  Ala alanine   I  Ile  isoleucine    
R Arg  arginine  C Cys cysteine  
K Lys lysine   S Ser serine 
D  Asp aspartic acid  L  Leu  leucine  
T Thr threonine  E  Glu  glutamic acid  
M  Met  methionine   V Val  valine 
F Phe  phenylalanine  N  Asn  asparagine  
W Trp  tryptophan  G Gly  glycine 
P Pro  proline   Y Tyr  tyrosin 
H  His histidine   Q  Gln  glutamine 
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4.3 BACTERIAL STRAINS 
 
Tab. 1: Used bacterial strains 
Species Strain Genotype Reference 
Escherichia coli DC10B dam+ ∆dcm ∆hsdRMS 
endA1 recA1 
(Monk et al., 2012) 
Escherichia coli DH5α endA1 hsdR17 (rK 
- mK+) supE44 thi-1 
recA1 gyrA (Nalr) 
relA1Δ(lacZYAargF) 
U169 deoR 
(Φ80dlacZΔM15) 
(Hanahan 1983) 
Escherichia coli XL-1 blue endA1 gyrA96 (nalR) 
thi-1 recA1 relA1 lac 
glnV44 F´[::Tn10 
proAB+ lacIq ∆ 
(lacZ)M15] hsdR17 
(rK- mK+) 
(Bullock et al., 1987) 
Escherichia coli BL21 (DE3)-RIL (E. coli B) F− ompT 
hsdS (rB− mB −) 
dcm + Tetr gal λ (DE3) 
endA Hte 
(argU ileY leuW 
Camr) 
(Greener et al. 1997) 
Staphylococcus 
aureus 
8325 NCTC 8325 (RN1)  (Novick and 
Richmond 1965) 
Staphylococcus 
aureus 
RN42220 derivative of NCTC 
8325 
(Iordanescu and 
Surdeanu 1976) 
Staphylococcus 
carnosus 
TM300  (Schleifer and 
Fischer, 1982) 
(Rosenstein et al., 
2009) 
Staphylococcus 
carnosus 
TM300 ∆ rodA TM300 ΔrodA::lox72 This study 
Staphylococcus 
carnosus 
TM300 ∆ ftsW1 TM300 ΔftsW1::lox72 This study 
Staphylococcus 
carnosus 
TM300 ∆ ftsW2 TM300 ΔftsW2::lox72 This study 
Staphylococcus 
warneri 
SG1 
 
 (Kloos & Schleifer 
1975) 
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4.4 MEDIA 
The culture media were autoclaved for 20 min at 121 °C and 2 bar. For the preparation 
of plates 15 g agar were added. 
  
Tab. 2: Used media and chemical composition 
 
Type Chemical composition 
B2-Medium 10 g/l Trypton                                            
25 g/l Yeast extract                                      
25 g/l NaCl                                                     
5 g/l Glucose                                             
1 g/l     K2HPO4 * 3H2O    
pH 7,5 
Basic (B)-Medium 10 g/l Pepton                                               
5 g/l Yeast extract                                                                             
5 g/l NaCl                                                     
1 g/l Glucose                                             
1 g/l     K2HPO4 * 3H2O                                   
pH 7.2 
Brain Heart Infusion (BHI)-Medium  37 g/l    Brain Heart Broth 
pH 7.2 
Luria Bertani (LB)-Medium 10 g/l Trypton                                               
5 g/l Yeast extract                                                                              
10 g/l NaCl 
pH 7.0                                                      
Super Optimal Broth (SOB) Medium 2% w/v Tryptone (20 g/l) 
0.5% w/v Yeast extract (5 g/l) 
8.56 mM NaCl (0.5 g/l) 
2.5 mM KCl (0.186 g/l) 
10 mM MgCl2 (anhydrous 0.952 g/l) or  
10 mM MgSO4 (heptahydrate 2.408 g/l) 
pH7.0 
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SOC Medium As above 
Additional 20mM glucose (3.603 g/l) 
 
Tab. 3: Antibiotic solutions 
 
Antibiotics Stock 
solution 
Solving 
solution 
Selection-
concentratio
n 
Purchased by 
Ampicillin 100 mg/ml H2Obidest 100 µg/ml Carl Roth GmbH, 
Karlsruhe 
Chlorampheni
col 
10 mg/ml EtOH (70 %) 10 µg/ml Carl Roth GmbH, 
Karlsruhe 
Kanamycin 30 mg/ml H2Obidest 30 µg/ml Carl Roth GmbH, 
Karlsruhe 
Tetracycline 25 mg/ml EtOH (70 %) 25 µg/ml Sigma-Aldrich 
Chemie GmbH, 
Taufkirchen 
All solutions were filter sterilized and stored at -20 °C. In terms of thermo stability 
autoclaved media were complemented at < 50 °C with its respective antibiotic. 
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Tab. 4: Used plasmids 
 
Plasmid Size Host Selection Reference 
pCX30Δ82cw 6.5 S. carnosus Cmr (10 μg/ml) (Strauß and Götz 
1996) 
pTX30Δ82cw 9.0 S. carnosus Tcr (12.5 μg/ml) (Strauß and Götz 
1996) 
pCX31H 4.8 S. carnosus Cmr (10 μg/ml) Albrecht 2012 
pCX33TLCH 6.0 S. carnosus Cmr (10 μg/ml) Albrecht 2012 
pBT2 6.3 S. carnosus 
E. coli 
Cmr (10 μg/ml) 
Amr (100 μg/ml) 
(Brückner 1997) 
pSG1 8.3 S. carnosus 
E. coli 
Cmr (10 μg/ml) 
Amr (100 μg/ml) 
Krismer 2012 
pRAB1 8.3 S. carnosus 
E. coli 
Cmr (10 μg/ml) 
Amr (100 μg/ml) 
(Leibig et al. 2008) 
pJet 2.9 E. coli Amr (100 μg/ml)  
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4.5 OLIGO NUCLEOTIDES 
 
Tab. 5: Used oligonucleotides 
 
Amplicon Primer fw 
with enzymes sites and enzyme 
Primer rv 
with enzymes sites and enzyme 
Size 
Amplicon 
[bp] 
RodA 
upstream 
attagttatagctagcacttcagaatctaactctgc 
NheI 
tacatgatatctgcagaagttccccttttaaattgc 
PstI 
1039 
RodA 
downstream 
tacagctagcctgcagtagaatgttttctgataacc 
PstI 
tatatataatgtcgacatccactttctcaagc 
SalI 
1494 
RodA ttaattggatcctaaattaggaggtattaatt 
BamHI 
atatcccgggcgctcgataacctg 
XmaI/SmaI 
1225 
FtsW1 
upstream 
tatgagctcgcgatatctatttagaatgatattagg 
EcoRV 
tacagtgtctctgcagtctaatatttgaagaaatcc 
PstI 
1364 
FtsW1 
downstream 
tatctatgtactgcagtaaagacgtattccataacg 
PstI 
acatcatgtgtcgaccttatgataatcttcaatcg 
SalI 
830 
FtsW1 ttaattggatcctaaattaggaggtattaatt 
BamHI 
tattaacccgggtaatgatgaacg 
XmaI/SmaI 
1228 
FtsW2 
upstream 
tatgtatatagatatctgcaacagaatcagcaatcg 
EcoRV 
taatctacatctgcaggagatatggaatataaatgc 
PstI 
1105 
FtsW2 
downstream 
tatatagatactgcaggtttcaactatctcacaacg 
PstI 
atcgagcgcggtcgactatttaactaatataattgg 
SalI 
1486 
FtsW2 ttaattggatcctaattaggaggtattaatt 
BamHI 
aataacccgggtaatgatgaacg 
XmaI/SmaI 
1207 
universal 
primer 
agagtttgatcmtggctcag aaggaggtgwtccarcc 1500 bp 
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4.6 ENZYMES 
Tab. 6: Used enzymes and supplier 
 
Enzym Supplier 
BamHI Thermo Scientific, Karlsruhe 
High Fidelity PCR Enzyme Mix Thermo Scientific, Karlsruhe 
KpnI Thermo Scientific, Karlsruhe 
Mutanolysine Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
NheI Thermo Scientific, Karlsruhe 
RNase Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
SalI Thermo Scientific, Karlsruhe 
T4-DNA-Ligase Thermo Scientific, Karlsruhe 
HindIII Thermo Scientific, Karlsruhe 
PstI Thermo Scientific, Karlsruhe 
EcoRI Thermo Scientific, Karlsruhe 
Phusion® hot start high-fidelity DNA 
polymerase 
Finnzymes Oy, Espoo (Finland) 
High fidelity polymerase, Taq 
polymerase  
Genaxxon BioScience GmbH, Ulm 
Lysostaphin Genmedics GmbH, Reutlingen 
Restriction endonucleases, alkaline 
phosphatase(CIAP),T4 
polynucleotide kinase (PNK), T4-
DNA ligase, high fidelity PCR 
enzyme Mix, Taq DNApolymerase 
Fermentas GmbH, St. Leon-Rot 
Restriction endonucleases New England Biolabs, Schwalbach 
Hen egg white lysozyme Serva, Heidelberg 
Trypsin, thrombin from bovine 
plasma, mutanolysin, 
desoxyribonuclease 1, ribonuclease 
Sigma, Deisenhofen 
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Tab. 7: Used molecular biological kits and their source of supply 
 
Source Kit 
Bio-Rad Laboratories, München InstaGene™ Matrix 
Fermentas GmbH, St. Leon-Rot Rapid Ligation Kit 
CloneJet™ PCR cloning Kit 
Lonza QCL-1000 Kit (Endotoxin detection) 
Endo Trap® Red Column (Endotoxin 
removal) 
QIAGEN GmbH, Hilden QIAex II Gel extraction Kit, QIAquick-Kit 
QIAGEN-Plasmid-Midi-Kit 
Stratagene GmbH, Heidelberg StrataClean®-Resin 
 
Tab. 8: Used molecular weight markers and their source of supply 
 
Supplier Product 
Fermentas, St. Leon-Rot GeneRulerTM 1 kb DNA ladder 
GeneRulerTM 
DNA ladder Mix 
PageRulerTM prestained protein ladder 
PEQLAB, Erlangen peqGOLD protein-Marker IV (prestained) 
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4.7 OTHERS 
 
Tab. 9: Other materials and solutions and their supplier 
 
Label Supplier 
10 x High Fidelity PCR Buffer inkl. 
MgCl2 
Thermo Scientific, Karlsruhe 
10 x Buffer Tango (with BSA) Thermo Scientific, Karlsruhe 
10 x Buffer O+ (with BSA) Thermo Scientific, Karlsruhe 
DNA Loading Dye (6x) Thermo Scientific, Karlsruhe 
dNTP Mix Thermo Scientific, Karlsruhe 
GeneRuler™ 1 kb DNA Ladder Thermo Scientific, Karlsruhe 
MgCl2 (25 mM) Thermo Scientific, Karlsruhe 
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4.8 CHEMICAL SOLUTIONS 
Tab. 10: Chemicals solutions 
 
Chemicals Source 
Acrylamid (Rotiphorese® Gel 30) Carl Roth GmbH, Karlsruhe 
Agar-Agar Carl Roth GmbH, Karlsruhe 
Agarose Biozym Scientific GmbH, Hessisch 
Oldendorf 
APS (Ammoniumpersulfate)  SERVA Electrophoresis GmbH, 
Heidelberg 
Brain Heart Broth Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
Bromphenolblue Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
BSA (Bovines Serumalbumin) Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
CaCl2 * 2H2O Carl Roth GmbH, Karlsruhe 
Chisom Fisher Scientific UK, Loughborough 
Coomassie Brilliantblau R-250 AppliChem GmbH, Darmstadt 
DAPI AppliChem GmbH, Darmstadt 
EDTA  Merck KGaA, Darmstadt 
Acetic acid 100 % p.a. VWR International GmbH, Darmstadt 
Ethanol absolut p.a. Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
Ethidiumbromide Carl Roth GmbH, Karlsruhe 
Glucose  SERVA Electrophoresis GmbH, 
Heidelberg 
Glycerol Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
Yeast extract Carl Roth GmbH, Karlsruhe 
HCl Carl Roth GmbH, Karlsruhe 
Imidazol Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
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Isopropanol Fisher Scientific UK, Loughborough 
KCl Merck KGaA, Darmstadt 
K2HPO4 * 3H2O Carl Roth GmbH, Karlsruhe 
KOH Merck KGaA, Darmstadt 
Methanol Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
Methylenblue Merck KGaA, Darmstadt 
MgCl2 Carl Roth GmbH, Karlsruhe 
NaH2PO4 * H2O Merck KGaA, Darmstadt 
Na2HPO4 * 2H2O Merck KGaA, Darmstadt 
NaCl Merck KGaA, Darmstadt 
NaClO4 Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
NaOH Merck KGaA, Darmstadt 
Pepton Carl Roth GmbH, Karlsruhe 
Phenol Carl Roth GmbH, Karlsruhe 
Pregallidermin B. Krismer, Tübingen 
Saccharose Carl Roth GmbH, Karlsruhe 
SDS (Sodiumdodecylsulfat) Carl Roth GmbH, Karlsruhe 
Temed (Tetramethylethylendiamin) Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
Tris AppliChem GmbH, Darmstadt 
Trypton Oxoid Ltd., Hampshire 
Xylose Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
β-Mercaptoethanol Merck KGaA, Darmstadt 
 
  
30 
 
4.9    COMPUTAL PROGRAMS AND DATABASES 
 
Tab. 11: Used computal programs and Databases 
 
Programs Reference 
Clone Manager 9 Scientific & Educational Software, Cary 
i-control 1.8 SP1 Tecan Group Ltd., Männedorf 
Kyoto Encyclopedia of 
Genes and Genomes 
http://www.genome.jp/kegg/kegg2.html 
LAS AF Leica Microsystems CMS GmbH, Wetzlar 
NCBI U.S. National Library of Medicine, Bethesda 
http://www.ncbi.nlm.nih.gov/ 
TMHMM 2.0 Krogh, et al., 2001 
http://www.cbs.dtu.dk/services/TMHMM/ 
TMRPres2D Spyropoulos, et al., 2004 
Phyre2 
 
© Structural Bioinformatics Group Imperial 
College, London 
www.sbg.bio.ic.ac.uk/phyre2/ 
HHprep http://toolkit.tuebingen.mpg.de/hhrep 
SOSUI engine ver. 1.11 http://bp.nuap.nagoya-u.ac.jp/sosui/ 
Quick 2D http://toolkit.tuebingen.mpg.de/quick2_D 
Image J 1.45s National Institutes of Health  
Zeiss LSM Image Browser 
Version 4.2.0.121 
Carl Zeiss MicroImaging GmbH 
Endnote X6 Thomson Reuters, Carlsbad 
Microsoft Office 2007 Microsoft Dtld. GmbH, Unterschleißheim 
NEBuilder™ http://nebuilder.neb.com/ 
Chem Biodraw 13 Perkin Elmer Cambridge Soft. 
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4.10    DEVICES 
Tab. 12: Used technical devices and their source of supply 
 
Device Model Supplier 
Incubation chamber B5042E Heraeus Holding GmbH, 
Hanau 
Bunsenburner Phoenix II eco Schuett-biotec GmbH, 
Göttingen 
Ice supply AF 100 Scotsman Ice Systems, 
Mailand 
Elektroporator Multiporator® Eppendorf AG, Hamburg 
Gel documentation 
system 
 LTF Labortechnik GmbH & Co. 
KG, Wasserburg/Bodensee 
Gel documentation 
system 
 Vilber Lourmat, Eberhardzell 
Heating block  Bachofer Laboratoriumsgeräte, 
Reutlingen 
HPLC 1200 series Agilent Technologies Inc.,  
Santa Clara 
Mikroscope DM5500 B Leica Microsystems GmbH, 
Wetzlar 
Mikrowave NN-SD456W Panasonic Corporation, Osaka 
Magnet stirrer RCT basics IKA®-Werke GmbH & CO. KG, 
Staufen IKA RCT IKAMAG 
PCR-Cycler Primus 96 plus MWG-Biotech AG, Penzberg 
pH-Meter Hydrus 300 Fisher Scientific UK, 
Loughborough 
Photometer Helios alpha Thermo Fisher Scientific Inc. 
Waltham 
Plate Reader Infinite M200 Tecan Group Ltd., Männedorf 
Ultrapurewater 
apparatus 
Milli-Q Plus PF EMD Millipore Corporation, 
Billerica 
Shaking incubator KF-4 
Innova 44 
Infors AG, Bottmingen 
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New Brunswick Scientific, 
Edison 
Power supply LKB-GPS 200/400 
2297 Macrodrive 5 
Pharmacia, Ratingen 
LKB Bromma 
Laminar Workflow SterilGARD VBM 
400 
Baker Company Inc., Sanford 
DNA-Sequencer  LI-COR 400L MWG Biotech, Ebersberg 
Camera Camera DC3 Leica Microsystems GmbH, 
Wetzlar 
Drying incubator T 6120 Heraeus Holding GmbH, 
Hanau 
Vortex Vortex Genie 2 Bender & Hobein GmbH, 
Zürich 
 
Scale Weighing machine  
BP 61-OCE 
special accuracy 
weighing machine 
Kern EW 4200-2NM 
Sartorius AG, Göttingen 
 
KERN & SOHN GmbH, 
Balingen 
 
Waterbath  Bachofer Laboratoriumsgeräte, 
Reutlingen 
Centrifuges Centrifuge 
Z 216 MK 
Centrifuge 
Multifuge X3R 
 
Table centrifuge 
Z 233 M-2 
Vakuumzentrifuge 
Univapo 100 H 
Hermle Labortechnik, Wehingen 
 
Thermo Scientific, Karlsruhe 
 
Hermle Labortechnik, Wehingen 
 
UniEquip Laborgerätebau- und 
Vertriebs GmbH, Planegg 
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4.11    CONSUMABLE MATERIALS AND PLASTIC ARTICLES 
 
Tab. 13: Used consumable material and plastic articles and their source of supply 
 
Supplier Product 
Eppendorf, Hamburg 1.5 ml & 2 ml Eppendorf reaction tubes 
(ERTs) 
GE Healthcare Europe, München 
(Whatman, Dassel) 
Whatman® Protran® nitrocellulose, 
filter sterilizer (0.2 μm), 
Greiner Bio-One, Frickenhausen FalconTM tube PS 12 ml,  
FalconTM tube PS 50 ml, 
single-use inoculating loop 
Henke Sass Wolf, Tuttlingen Injection Norm-Ject (1 ml, 5 ml, 20 ml) 
Millipore, Schwalbach Filter Millipak Express 20 (0.22 μm), 
StericupTM 
PES membrane (0.22 μm) 
Molecular Bioproducts, San Diego 200 μl reaction tubes 
Roth, Karlsruhe glass beads (0.25-0.5 mm) 
Thermo Fisher Scientific  
 
96 well plate NunclonTM surface 
96 well plate Nunc black U96 PP-0.5 
ml 
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4.12    METHODS FOR WORKING WITH BACTERIA 
4.12.1 CULTIVATION OF BACTERIA 
Cultures of staphylococci were cultivated in B-medium on a shaker at 37 °C and 150 
rpm. When xylose inducible gene expression was carried out, cells were cultivated 
without glucose (catabolite repression). The bacterial growth was observed at an 
optical density OD578 nm in a photometer. Usually, cells were grown until an OD578 = 
0.6 and the gene expression was induced by adding in total 0.5% xylose. E. coli strains 
were cultivated with B-medium, too.  
 
4.12.2 STORAGE OF BACTERIA 
For medium-term storage bacterial strains were plated on BM plates and incubated 
overnight at 37 °C. The plates were stored at 4 °C in case of E. coli for 2-3 weeks and 
for S. carnosus for 6-8 weeks. For long-term storage of bacteria one volume of 
overnight culture was mixed with one volume of autoclaved freeze-medium (65% 
glycerol, 0.1 M MgSO4, 25 mM Tris/HCl, pH 8.0) and stored at -70 °C. Bacteria were 
harvested by centrifugation for 10-20 min at 4 °C and 4’500 rpm. 
 
4.13    METHODS FOR WORKING WITH NUCLEIC ACIDS 
4.13.1 ISOLATION AND PURIFICATION OF NUCLEIC ACIDS 
Solutions and buffers were assembled using fine chemicals and deionized purified 
Milli-Q water. The DNA was kept at 4 °C for short-term storage whilst at -20 °C long 
term storage. 
 
4.13.2 ISOLATION OF PLASMID-DNA FROM E. COLI 
High amounts of plasmid-DNA were isolated from 50-100 ml culture using the 
"QIAGENPlasmid- Midi-Kits" (QIAGEN GmbH, Hilden). Herewith, DNA was obtained 
by the principle of alkaline lysis (Birnboim and Doly 1979) and is further purified by 
anion-exchange chromatography. The isolation was carried out using the producer‘s 
manual. Small amount of ultrapure DNA was isolated from 4 ml culture by "QIAprep-
spin columns" (QIAGEN GmbH, Hilden), which works in a similar way but with a 
different neutralization buffer. 
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4.14    BUFFERS AND SOLUTIONS 
Tab. 14: Buffers and solutions 
 
Buffer Name  Contents 
Phenol/"Chisom" (Roti® phenol) 25 parts neutral phenol, 24 parts CHCl3, 1 part 
isoamyl alcohol 
buffered with 20 mM Tris/HCl pH 8.0 
Chisom 24 parts CHCl3, 1 part isoamyl alcohol 
3M Na-acetate 3 M NaAc, pH 5.2 (adjusted with acetic acid) 
Milli-Q water Water was purified using the Milli-Q apparatus 
and autoclaved for later usage with nucleic acid 
50x TAE-buffer 2 M Tris/HCl, 0.5 M NaAc, 50 mM EDTA, pH 7.8 
E1 solution 25% sucrose, 10% Ficoll, 0.4 mg/ml RNase, 1 
mg/ml lysozyme, 
filled up to 2 ml with 1x TAE-buffer. 
 
4.15    ISOLATION OF PLASMID-DNA FROM S. CARNOSUS 
High amounts of plasmid-DNA were isolated from 50-100 ml culture using the 
"QIAGENPlasmid-Midi-Kits" (QIAGEN GmbH, Hilden). Cells from an overnight culture 
were resuspended in P1 buffer (up to 100 ml culture in 4 ml buffer). Per 4 ml buffer 30-
45 μl Lysostaphin (0.5 mg/ml) were added. The cell solution was incubated in the water 
bath for 20 min at 37 °C for cell wall degradation. The additional steps were carried out 
according to the manufacturer‘s protocol. Small amounts of DNA were isolated with 
the "QIAprep-spin columns" (QIAGEN GmbH, Hilden). From 4 ml overnight culture 
plasmid DNA was isolated. After resuspension of cells in 250 μl buffer P1, 20 μl 
Lysostaphin (0.5 mg/ml) was added for cell wall degradation. The incubation took place 
in a water bath over 20 min at 37°C. The additional steps were carried out according 
to the manufacturer‘s protocol. 
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4.16    SEPARATION OF PLASMID PROFILES ACCORDING TO ECKHARDT 
The lysis according to Eckhardt (Eckhardt 1978) was carried out to quickly check 
whether or not plasmids contain inserts or not judged by a shift in plasmid size. 
Originally set up for E. coli only, cells were lysed by lysozyme and SDS during the gel 
forerun avoiding shear forces. For working with staphylococcal cells 20μg/ml 
Lysostaphin were added to the lysis buffer E1 (25% Saccharose, 10% Ficoll, 0,4 mg/ml 
RNase, 1mg/ml Lysozym solved in TAE-Puffer) The gel was composed of 0.8% - 1.5% 
(w/v) agarose in 1x TAE-buffer. After boiling, 2 ml of 10% SDS-solution were added 
per 100 ml agarose solution at ca. 60°C. The solidified gel was covered with 1x TAE 
buffer straightaway before starting the gel run. A single colony was picked with a tooth 
pick and resuspended in 10 μl 1x TAE buffer. Afterwards, 20 μl of E1 solution was 
added and carefully mixed. Cell suspension of 20 μl was loaded on the agarose gel 
and left for 5 min. The gel was pre-run for 30 min at 20 V and further for 1-3 hrs at 120 
V. The gel was watered subsequently for 30 min and stained for 20 min in ethidium 
bromide. 
 
4.17    ISOLATION OF CHROMOSOMAL DNA OF S. CARNOSUS 
4.17.1 PHENOL CHLOROFORM EXTRACTION 
The isolation of chromosomal S. carnosus-DNA was carried out after a modified 
protocol according to Marmur (Marmur 1961). The cells were lysed almost totally and 
in the adjacent steps contaminants, such as cell debris and proteins were removed. 
Cells of an overnight culture were harvested for 3 min at 13’000 rpm by centrifugation 
in 2x 2 ml ERTs. Cell sediments were resuspended in 400 μl buffer P1 and 40 μl 
Lysostaphin (0.5 mg/ml) were added. The mixture was thoroughly vortexed and 
incubated for 30 min at 37°C in a water bath, until the cell solution became quite 
viscous. Afterwards, 40 μl of a saturated SDS solution (45%) was added, vortexed for 
1 min, and incubated for another 5 min at 37 °C in the water bath. Subsequently, 100 
μl 5 M NaClO4 (dissolved in water, sterile filterized) were added and vortexed for 1 min 
Afterwards, 500 μl Roti® Phenol was added, vortexed for 1 min and centrifuged for 30 
min at 13’000 rpm. The upper phase was transferred to a new 1.5 ml ERT, using a 
cropped pipette tip. Subsequently, 500 μl Chisom was added and the solution was 
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vortexed for 1 min the phases were separated by centrifugation for 30 min at 13’000 
rpm. The upper phase was transferred to a new 1.5 ml ERT, 0.7 volumes of 
isopropanol (= 350 μl) were subsequently added and the solution was mixed 
thoroughly on a vortex. The DNA was fished using a yellow pipette tip, transferred to 1 
ml 70% EtOH and centrifuged for 30 min at 13’000 rpm. The DNA sediment was 
washed once again with 0.5 ml 70% EtOH. Finally, the DNA was vacuum dried by a 
Univapo 100 H vacuum centrifuge and dissolved in 50-100 μl Milli-Q-water. The DNA 
was stored overnight at 4 °C and later at -20 °C for long term storage. 
 
4.17.2 DETERMINATION OF DNA CONCENTRATION 
The concentration of DNA was determined photometrically at an extinction of 260 nm. 
Absorption of 1 refers to a concentration of 50 μg/ml double-stranded DNA. Low DNA 
concentrations were estimated in comparison with standard-DNAs of known 
concentration in an EtBr stained agarose gel.  The extinction ratio of 260/280 is used 
to determine the purity of the DNA with 1.8 for DNA without RNA or protein 
contaminations. 
 
4.18    ANALYSIS OF DNA BY GEL ELECTROPHORESIS 
4.18.1 AGAROSE GEL ELECTROPHORESIS OF DNA FRAGMENTS 
DNA fragments of different size were separated by electrophoresis in TAE-agarose 
gels (14x 11 cm, 0.8-2.0% agarose in TAE buffer) at 120 V. Before the gel run, DNA 
was mixed with ¼ volumes of 5x DNA sample buffer (25% Ficoll® 400,  
50 mM EDTA, 0.25% bromophenol blue, 0.25% xylene cyanol). The sample volume 
for analytical gels was 20 μl and was up to 100 μl for preparative gels. The DNA-
standards GeneRuler 1 kb DNA ladder or DNA ladder mix were used as the marker. 
DNA of analytical gels was stained in an EtBr staining solution (2 μg/ml) for 10 min, 
decolorized in water for 5-10 min and photographed under the UV-light. Preparative 
gels were stained in methylene blue (0.1% in dH2O) for 5-10 min and decolorized for 
30-60 min in water. Thereby, DNA bands became visible and were excised from the 
agarose gel using a scalpel. 
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4.18.2 ISOLATION OF DNA FROM AGAROSE GELS 
The to-be-recovered DNA fragment was excised using a scalpel and was collected in 
a 2 ml ERT. The DNA was recovered using the "QIAquick Gel Extraction-Kit“. The 
agarose was dispersed at 50 °C in a heat block, adsorbed to glass particles packed in 
columns and eluted after a wash step with TE-buffer. This system is very suitable for 
DNA fragments above 4000 nt. The isolation was carried out according to the 
manufacturer‘s protocol. 
 
4.19    MODIFICATION OF DNA IN VITRO 
4.19.1 CLEAVAGE, DEPHOSPHORYLATION AND LIGATION OF DNA 
DNA cleavage with restriction endonucleases (RENs) was carried out according to the 
manufacturer‘s protocol. For the analytical DNA cleavage 0.05-0.5 μg of DNA were 
applied, and for preparative use 0.5-5 μg of DNA was sufficient. The minimum and 
maximum reaction volume was set to 20 μl and 60 μl, respectively. All reactions with 
RENs were carried out at 37°C, but SmaI at 30°C. For the analytical purpose a reaction 
time of 1.5 hrs and for the preparative usage a reaction time of 2.5-3 hrs were applied. 
The RENs with their appropriate buffers were obtained from New England Biolabs 
GmbH and Fermentas GmbH.  
The 5‘-phosphate group of the free DNA-ends was enzymatically removed by calf 
Intestine alkaline phosphatase (CIAP), after the hydrolytic cleavage of a vector by a 
REN. This dephosphorylation prevents the linearized vector from religation. The CIAP 
was applied either directly to the enzyme reaction buffer, or CIAP reaction buffer was 
applied to the purified and in Tris-buffered vector fragment. Per μg DNA 1-10 U of CIAP 
were added, and the reaction batch was incubated for 1 h at 37°C. Later, the CIAP 
was heat-inactivated for 15 min at 65°C. 
The ligation of free DNA ends was carried out with T4-DNA ligase. Therefore, DNA 
was prepared using preparative agarose electrophoresis. The vector–insert ratio was 
1:4 or 1:8. The ligation was carried out either with the 5x rapid ligation buffer and 2 μl 
ligase over 45 min or with the 10x ligation buffer and 1μl ligase at 8-14°C overnight. 
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4.19.2 POLYMERASE CHAIN REACTION 
The polymerase chain reaction (PCR) makes it possible to amplify specific DNA 
fragments in vitro (Mullis and Faloona 1987; Bej et al. 1991). Synthetic oligonucleotides 
(Primer) complementary to the target sequence and flanking the to-be-amplifying 
region are used as start points for a thermostable DNA-polymerase. Primer ends often 
were modified to include recognition sites for RENs or an optimized ribosomal binding 
site. The basis of this technique is a DNA-Polymerase, of which the optimized 
temperature is ca. 75°C. In general, the Taq polymerase derived from Thermoproteus 
aquaticus was used for analytical and colony PCRs. The high-fidelity polymerase, a 
combination of Taq and pfu DNApolymerase of Pyrococcus furiosus, which possesses 
3' to 5' exonuclease proofreading activity, was used for preparative approaches to 
amplify particular DNA fragments. The "Phusion® Hot Start High-Fidelity DNA 
Polymerase" was used for Fusion-PCR. Common PCR was carried out in 50 μl 
reaction volume with 1x reaction buffer containing MgCl2, 25 μM dNTP mix (dATP, 
dCTP, dGTP, dTTP), 0,5 μl primer (100 pmol/μl), 2 U polymerase and 100 ng DNA 
template or 1-2 μl chromosomal DNA. A standard PCR-protocol is as follow 
 
Tab. 15: Standard PCR protocol 
 
 Denaturation Annealing Elongation 
Start 94 °C / 5.00 min   
Cycle (1-25) 94 °C / 0.50 min estimated /  
1.50 min 
72 °C / estimated 
End (Cycle 26) 94 °C / 0.50 min estimated /  
1.50 min 
72 °C / 12 min 
Store at 8°    
 
Primer-annealing temperatures were estimated from the effective binding nucleotides 
to the target sequence using GCG Wisconsin Package 10 or the information provided 
by biomers.net but can also be estimated by using the formula: 
(𝐴 + 𝑇) ∗ 2 + (𝐺 + 𝐶) ∗ 4 = 𝐴𝑛𝑛𝑒𝑎𝑙𝑖𝑛𝑔 𝑡𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 
Unless specifically described by the Kits manufacturer, 1.000 nt are elongated in 1 min 
by DNA polymerase. The last cycle includes a doubled elongation time. Afterwards, 
10% of the PCR-reaction was analyzed on an analytical agarose gel. 
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4.19.2.1 Purification of DNA products amplified by PCR 
Two methods for the purification of the PCR products were used. Either the DNA was 
purified according to the protocol of the QIAquick PCR Purification Kit when the PCR 
products were pure and visible as single bands on the analytical agarose gel, or the 
particular DNA fragment was cut out of a methylene blue stained preparative agarose 
gel and further purified according to the protocol of the QIAquick Gel Extraction Kit. 
 
4.19.3 COLONY PCR 
(Tested for E. coli strains & S. carnosus TM300) 
Colony-PCR is a rapid analytical method to screen for positive clones after plasmid-
delivery. In this approach the whole bacterial colony was taken and its DNA served as 
a template of the PCR reaction instead of a purified DNA. To verify a particular DNA 
fragment the adjacent primers were chosen and the annealing temperatures was 
calculated. Using specific primers complementary to the vector and the insert made it 
possible to control the orientation of the inserted DNA, which was easily shown without 
any further purification and cleavage of the DNA by RENs. The analytical PCR was 
carried out in 20 μl total reaction volume by the Taq DNA polymerase for 20-25 cycles. 
A single colony was picked with a sterile pipette tip or a toothpick and transferred first 
into the prepared PCR-reaction solution and afterwards to a freshly prepared solid BM-
agar plate complemented with the respective antibiotic. Afterwards, 5-10 μl of the PCR 
reaction were analyzed on an analytical agarose gel. 
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4.19.4 FUSION PCR (OVERLAP PCR) 
Great efforts are required to construct gene cassettes flanked by promoter and protein-
tag areas and additional recognition sites. By PCR fragments are generated, which 
have to be cloned step by step into the respective plasmid. The difficulties are further 
increased the longer the generated PCR product has become. In this case, fusion PCR 
or overlap PCR is a favorable method to construct a fragment directly in separate PCR 
reactions. In the last PCR-reaction the two generated fragments are fused. The two 
separated PCR reactions were carried out using the High-Fidelity DNA-polymerase. 
After purification of the PCR products the filling reaction was done using Phusion® 
High-Fidelity DNA Polymerase. 
 
 
Figure 4: Principle of fusion-PCR.  
In two separated PCR-reactions the fragments to be fused are generated. In the last step the 
fusion product is generated by a polymerase producing less mistakes as i.e. Phusion® High-
Fidelity DNA Polymerase  
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4.20    GIBSON ASSEMBLY  
Gibson assembly is an isothermal, single-reaction method for assembling multiple 
overlapping DNA molecules by the concerted action of a 5´ exonuclease, a DNA 
polymerase and a DNA ligase. First, DNA fragments were recessed, yielding single-
stranded DNA overhangs that could be specifically annealed. T5 exonucleases 
removed nucleotides from the 5´ends of double-stranded DNA molecules. 
Complementary single-stranded DNA overhangs annealed, Phusion DNA polymerase 
filled the gaps and Taq DNA ligase sealed the nicks. T5 exonuclease is heat-liable and 
it inactivated during the 50°C incubation (Gibson, 2009). The Primer were designed 
using the NEBuilder™ computal program provided by NEB. 
 
 
Figure 5: Principle of Gibson Assembly:  
Two adjacent DNA fragments (magenta and green) sharing terminal sequence overlaps 
(black) were joined into a covalently sealed molecule in a one step isothermal reaction. 
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4.20.1 SEQUENCE VERIFICATION BY DNA SEQUENCING 
DNA sequencing was carried out by the research assistants of the laboratory according 
to the chain termination method using an automatic Li-COR sequencer with fluorescent 
labeled sequence primers (Sanger et al., 1977). For sequencing of chromosomal DNA 
20-25 μg DNA were applied. The sequence reaction was carried out according to the 
cycle sequencing principle, with the “Thermo Sequenase fluorescent labeled prime 
cycle sequencing kit (Sears et al. 1992). One reaction contained 13.5 μl DNA, 0.5 μl 
DMSO and 1 μl sequencing primer (2 pmol). The analysis of DNA sequences was 
carried out by the LI-COR software “Data Collection“ and “Image Analysis“ (Li-COR 
Inc.). In one sequence-run 500-750 nucleotides could be identified. The sequencing 
reaction of plasmid DNA contained 0.5-1.0 μg DNA and up to 900 nucleotides could 
be identified. Alternatively, samples were sent to the sequencing company GATC in 
Konstanz. PCR products of the to-be-sequenced DNA region were amplified from 
genomic DNA by High-Fidelity DNA-Polymerase or isolated purified plasmid-DNA was 
sent directly.  
In general, DNA sequences were analyzed by VectorNTI suite 10.3, BioEdit and the 
GCG Wisconsin Package 10. The BLAST program was used for the comparison of 
DNA and amino acid sequences, over the internet at “National Center for 
Biotechnology Information“(Altschul et al. 1990; Altschul et al. 1997).  
 
4.21    TRANSFORMATION OF BACTERIA 
4.21.1 TRANSFORMATION OF E. COLI BY HEAT SHOCK 
 
4.21.1.1 Preparation of competent E. coli cells  
40 ml Basic-medium were inoculated 1:200 with ONC of E. coli strain DH5α, DC10b or 
XL1-blue respectively. Cells were grown until an OD578 = 0.4 was reached. Afterwards, 
they were cooled down on ice for 10 min before harvesting by centrifugation at 5’000 
rpm for 10 min at 4°C. The cell sediment was resuspended in 20 ml ice-cold 50 mM 
CaCl2 and was incubated for 25 min on ice. Afterwards, cells were spun down by 
centrifugation at 5’000 rpm for 10 min at 4°C. The cell sediment was resuspended in 
the heat shock buffer (2 ml of 50 mM CaCl2 and 500 μl 50% glycerol), separated into 
aliquots of 100 μl each, and stored at -20°C (Dagert and Ehrlich 1979). 
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4.21.1.2 Transformation of competent E. coli cells 
Cells were thawed on ice for 5 min and 10 μl ligated plasmid or 1 µl isolated plasmid 
was added. The cell solution was incubated at 43°C for 90 sec in a water bath and 
cooled on ice again. Subsequently, 1 ml B-medium was added and the cell solution 
was incubated for 1-1.5 hrs shaking at 37°C. Afterwards, 100 μl cell cultures were 
spread each on two BM agar plates, complemented with the respective antibiotics, and 
incubated overnight at 37°C. Grown colonies were either transferred to another plate 
or directly tested whether they included the correct plasmids ( 4.16). 
 
4.21.2 TRANSFORMATION OF S. CARNOSUS  
4.21.2.1 Preparation of protoplasts 
(Götz, F. et al., 1983; Götz, F.  and Schumacher, 1987) 
300 ml B-media (1 l flask with baffle) were inoculated with 1 ml ONC of S. carnosus 
TM300. Cells were grown shaking until OD578 = 0,35-0,45 at 37°C. After cooling down 
on ice (10 min) cells were transferred to sterilized centrifuge tubes and spun down for 
20 min by centrifugation at 4.500 rpm and 4°C. The sedimented cells were 
resuspended in 30 ml SMMP-75 media and transferred to sterile 50 ml falcon tubes. 
Afterwards 10 μl of a filter sterilized Lysostaphin solution (0.5 mg/ml) was added and 
the whole mixture was incubated overnight for 12-16 hours at 30°C without shaking. 
The formation of protoplasts was monitored by light microscopy. When the cells were 
singularized and spheroblasts were visible lysis was stopped. Therefore, the 
protoplasts were spun down by centrifugation for 20 min at 4.500 rpm and RT. After 
the supernatant was discarded, residues of lysostaphin were removed by washing with 
5 ml SMMP-75 media. The protoplast sediment was resuspended carefully in 2 ml 
SMMP-75 media and aliquoted in 300 μl portions in 12 ml Greiner tubes. The 
protoplasts were stored at -70°C.  
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4.21.2.2 Transformation of S. carnosus TM300 protoplasts 
300 μl protoplasts were slowly thawn on ice (10 min). The DNA (5-70 μl, 0.5-1.0 μg) 
was pipetted on the edge of the 12 ml Greiner tube. Adjacent, the DNA was embedded 
by 2 ml Fusogen (40 g polyethylene glycol 6000, 50 ml 2x SMM, filled up with 100 ml 
dH2O; filter-sterilized) and flushed into the protoplast solution. During the 
transformation the tube was carefully rotated and inverted for exactly 2 min (PEG 6000 
can damage the protoplasts when extending the transformation time). Addition of 7 ml 
SMMP-75 media stopped the transformation. Cells were spun down for 20 min by 
centrifugation (4.500 rpm, RT). The supernatant was discarded and the protoplast 
sediment was resuspended in the media reflux and plated on two DM3 agar plates 
(Chang and Cohen, 1979; Götz, F.  and Schumacher, 1987), respectively. The DM3 
agar-plates were incubated for 3-4.5 h at 37°C for regeneration of the cell walls. 3 ml 
soft agar (CY3-soft agar, Na-succinate solution, Mix-solution in the proportion of 5:5:1) 
including the relevant antibiotics in a 10 fold concentration were poured on the pre-
incubated DM3 agar-plates. The DM3 agar-plates were incubated for 2-4 days at 37°C 
until colonies were formed.  
 
4.21.2.3 Transformation of S. carnosus by electroporation 
The transformation of staphylococcal cells with DNA by electroporation is performed 
according to the protocol of Löfblom (Löfblom et al., 2007). 
 
4.21.3 PREPARATION OF ELECTRO-COMPETENT S. CARNOSUS CELLS 
For the preparation of electro-competent staphylococci the cells were grown overnight 
in B-Medium. 100 ml of B2 Medium were then inoculated with a 1:200 dilution of the 
overnight culture and grown to an OD578 of 0,7 (37°C, 150 rpm). Growth was stopped 
by incubating the cells on ice for 15 min The suspension was centrifuged (10 min, 5000 
rpm), and the cells were washed three times with H2Obidest (100 ml, 50 ml und 20 ml), 
lowering the volume stepwise and again two times with cold 10% glycerol (10 ml and 
5 ml). Finally the cells were pelleted in 2 ml 10% glycerol and 100 µl aliquots were kept 
at -80°C. 
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4.21.4 ELECTROPORATION BUFFER 
For transformation the cells were thawn on ice and then incubated for 30 min at room 
temperature. Centrifugation for 2 min at 12.000 rpm and a washing step with 500 µl 
electroporation buffer (EC; 0,5 M saccharose, 10% glycerol) were performed 
afterwards. The pellet was washed again and solved in 85 µl EC. 4-6 mg plasmid DNA 
was added. The cells were transferred into a cuvette (1 mm gap) and the 
electroporation was performed with the settings 2500 V and 5 ms. Immediately 1 ml 
B2-Medium was added and the cells were incubated for at 30°C or 37°C for two hours 
(150 rpm). 200 µl and 800 µl of the transformed cells were plate on agar-plates 
(selection medium) and incubated at 30°C or 37°C for 24-48 h.  
A slight modification of this protocol was that, electro competent cells were spun down 
immediately at 5000 rpm and 4°C for 15 min the cells were then resuspended in 85 µl 
EC buffer, containing of 0.5 M sucrose in 10% glycerol, before the transforming plasmid 
was added in a maximal volume of 15 µl (Yu et al., 2010). 
 
4.22    CONSTRUCTION OF THE KNOCK OUT VECTORS 
In S. carnosus TM300 the genes ftsW1, ftsW2, and rodA are encoded by Sca_0739 
(1228bp), Sca_1886 (1207bp), and Sca_1584 (1217bp) respectively. For gene 
deletion, an approximately 1000 bp region up- and downstream of each gene was 
amplified by PCR. Both DNA fragments were cloned into the pJet vector using a 
CloneJet® kit from Fermentas resulting in pJet rodAup and pJet rodAdown which were 
used to transform chemo-competent E. coli Xl1-blue cells. Each insert was cut again 
from the particular vector by using the restriction enzyme site introduced by the 
amplification primers. We used SalI and PstI for the downstream regions and NheI and 
PstI for the up-stream regions. The knock-out (KO) vector pBT2 (Brückner, 1997) was 
cut with the enzymes SalI and NheI resulting in a linear vector. A triple ligation of the 
up and down-stream fragments and the cut pBT2 lead to a full circular vector (pBT2up-
down) containing a PstI enzyme site between the up and down-stream fragments. The 
aphAIII resistance cassette including the lox66 and the lox71 recognition site for the 
cre-recombinase and the PstI restriction sites (Leibig, Martina et al., 2008) was 
amplified and cloned into the PstI digested pBT2up-down vector resulting in the knock- 
out vector pBT2rodA. This vector first transformed chemically E. coli XL1-blue and was 
then isolated again to be sequenced. A plasmid containing the correct insert was then 
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electroporated into S. carnosus TM300 as described (Lofblom et al., 2007)(4.21.2.3) 
with slight modifications. For FtsW1 and FtsW2 the procedure was according to that 
listed above with the exception that the forward primer for the up-stream region does 
not contain a NheI site but an EcoRV site. 
  
Figure 6: pBT2 rodA knock out vector. 
Up- and Down-stream region of rodA were cloned in the vector with the restriction enzymes 
NheI/PstI and SalI/PstI respectively. The kanamycin resistance cassette flanked by the lox-
sites was cloned in with the PstI restriction enzyme. The KO vectors for ftsW1 and ftsW2 were 
constructed accordingly.  
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4.23    INACTIVATION OF CHROMOSOMAL GENES IN S. CARNOSUS TM300 
The method is based on the exchange of genes in the genome of S. carnosus via the 
homologous recombination. Herewith, the chromosomal encoded gene of interest can 
be exchanged by an antibiotic resistance marker. This method is called “gene knock-
out“. The shuttle vector pBT2 was used, which has a temperature sensitive replicon for 
staphylococci (Brückner, R., 1997(Brückner, 1997). No plasmid replication takes place, 
when cultivated above 30°C. As selection marker, the kanamycin resistance cassette 
derived from plasmid pBT2 srtA was used and the inactivation vector was cloned in E. 
coli (Leibig, M. et al., 2008). The flanking regions of the target sequence were cloned 
into pBT2 (optimal size: each >1kb length and the to-be-deleted region was replaced 
by the resistance cassette (4.22). The constructed plasmid was verified by sequencing, 
and inserted into S. carnosus TM300 by protoplast transformation (4.21.2.2). The 
selection occurred by the vector mediated resistance to chloramphenicol (10 µg/ml 
Cm) on BM agar plates. Plasmid DNA was isolated and the inserted genes were 
controlled by restriction enzyme analysis. Subsequently, an overnight culture was 
inoculated (50 ml) and cells were grown at 30°C for the plasmid replication in the 
presence of chloramphenicol. Afterwards, 50 ml preheated medium containing 7.5 
μg/ml Kanamycin were inoculated with the overnight culture (1:1000) and incubated at 
40°C in a water bath overnight. Now, the cells were cured of the pBT2 knock out 
plasmid, as its replication stopped at 40°C and, consequently, the plasmid was diluted. 
50 ml preheated medium without antibiotics was inoculated 1:1000 with the overnight 
culture and incubated overnight at 40°C. From a dilution series (1x 10-5 -1x 106) of 
overnight grown S. carnosus colonies were picked on kanamycin and Cm10 agar 
plates and incubated overnight at 37°C. S. carnosus clones growing on kanamycin but 
not on chloramphenicol lost their plasmid, but, integrated the resistance cassette into 
the chromosome. Contrary, S. carnosus colonies, which were able to grow on both 
kanamycin and chloramphenicol still carried the plasmid. Putative KO clones were 
tested by PCR and sequencing of the respective region. 
 
49 
 
 
 
Figure 7: Knock out procedure 
Procedure for homologous recombination using the plasmid pBT2 according to (Brückner, 
1997). Different temperature steps exploiting the temperature sensitive origin of replication for 
staphylococci of the pBT2 plasmid leads to a dilution of the plasmid and homologues 
recombination between the plasmid and the respective region in the chromosome. 
 
 
4.24    REMOVAL OF THE RESISTANCE MARKER 
Once an antibiotic resistance marker is integrated into the genome, it cannot be reused 
for another gene knock out. Therefore, the kanamycin resistance cassette aphIII was 
flanked by the so-called lox (locus of x-over P1)-sites, lox66 and lox71. After the 
integrated antibiotic cassette was confirmed by sequencing, it was excised using Cre-
recombinase, which specifically recognizes lox66 and lox71 and removes the space 
in-between, generating a lox72-site (Leibig, M. et al., 2008). The latter is poorly 
recognized by the Cre-recombinase. Consequently, another gene knock out can be 
carried out in this strain with a kanR cassette, which might be used again with lox-sites. 
The constructed S. carnosus mutant strain was protoplast transformed with the cre-
recombinase gene encoded on pRAB1 (Leibig, M. et al., 2008) and selected for Cm10 
resistance at 30°C. Colonies were picked on Cm10 and Kan 7.5 agar plates, and 
incubated at 30°C overnight. The colonies, which were able to grow on both selection 
media, were streaked on BM and Cm10 agar plates and incubated overnight at 37°C. 
Strains without plasmid were not able to grow on Cm10 plates anymore. 
  
30°C 
Select cassetteR
30 µg/ml Kan
Select vector R
20 µg/ml Cm
40°C
No selection
37°C
Select cassetteR
7,5 µg/ml Kan
40°C
Select cassetteR
7,5 µg/ml Kan
40°C
Select cassetteR
7,5 µg/ml Kan Select cassette R
7,5 µg/ml Kan
1:100
1:100
1:100
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4.25    CONSTRUCTION OF THE COMPLEMENTATION VECTORS 
Complementation of the RodA-mutant was achieved with the pCX33rodA vector. 
Therefore the rodA gene was amplified by PCR with primers containing restriction site 
for BamHI (forward), including the native SD sequence, and SmaI (reverse) resulting 
in a 1229 bp fragment. This gene region was inserted into a derivate of the pCX31 
vector (Wieland et al., 1995) under the control of a xylose inducible promoter resulting 
in the pCX31rodA. The S. carnosus ΔrodA strain was transformed with this plasmid 
gaining a complemented mutant strain (4.21.2.3). Plasmid isolation and sequencing of 
the cloned region confirmed the complementation. According to this procedure the 
ftsW1 and ftsW2 mutants were also complemented. 
:  
Figure 8: Plasmid map of pCX31_rodA 
The xylose inducible complementation vector is displayed with all improtant features like the 
inducible promoter XylA, the xylose regulator XylR, the chloramphenicol resistance gene cat 
and the complementary gene are displayed. The construction of the other vectors was 
performed according to this one. 
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4.26    MUROPEPTIDE ANALYSIS BY UHPLC 
All strains were grown in B-Medium up to an OD578 = 0.7. The peptidoglycan of the 
study strains was isolated, then digested with a muramidase, and analyzed by HPLC 
essentially as described before (Bertsche, U. et al., 2013) (Cecolabs; Tuebingen, 
Germany). The analyses were done on a Waters Acquity H-Class (UPLC) with a 
Prontosil C18-(120-3-C18) 150*4.6 mm AQ 3.0 µm column (Bishoff, Leonberg, 
Germany), but a protocol adjusted for HPLC or an Agilent 1200, using a Prontosil C18-
(120-3-C18) 250*4.6 mm AQ 3.0 µm from Bishoff (Leonberg, Germany). The gradient 
of 150 min started with 100 mM sodium phosphate + 5% methanol (buffer A) and ran 
to 100mM sodium phosphate + 30% methanol (buffer B). 
 
4.27    MASS SPECTROMETRY (MS) ANALYSIS.  
HPLC peaks-of-interest were collected and analyzed by MS. The liquid 
chromatography system used was an Agilent HPLC-MS-System Modell 1200 
connected to an Ultra Trap System. Muropeptides were separated on a Prontosil C18-
(120-3-C18) 250*4.6 mm AQ 3.0 µm from Bishoff (Leonberg, Germany). The gradient 
started with solvent A (0.1% formic acid) for 5 min, followed by a linear gradient in 60 
min to 20% Solvent B (0.06% formic acid in methanol) with a flow rate of 0.5 ml/min. 
The sample volume was 100 µl. For ionisation ESI positive and negative was 
alternated. The mode was set on Ultra Scan Capillary with a current of 3.5 kV. The 
nebulizer was set on 40 psi and dry gas was 12.0 l/min. The temperature was 350°C 
The software used was the 6300 Series Trap Control Version 6.1, of Bruker Daltonik. 
 
The high-resolution LC-ESI-MS and MS/MS measurements were carried out on a 
Bruker Daltonics MaXis 4G connected to a Dionex Ultimate 3000 system using a 
reversed-phase Prontosil C18-(120-3-C18) 250*4.6 mm AQ 3.0 µm column from 
Bishoff (Leonberg, Germany) and a linear gradient elution with solvents A (0.1% formic 
acid) and B (0.06 % formic acid in acetonitrile starting at 10 % B to 100 % B in 140 min 
at a flow rate von 0.3 ml/min. The acquisition parameters for the positive ion polarity 
were a capillary voltage of 4.5 kV and an end plate offset of -500 V. The nebulizer 
pressure was set to 2.0 bar and dry gas flow to 8.0 L min¯1 at a dry heater temperature 
of 200°C. The measurements were internally calibrated using sodium formate as a 
reference. Peaks had been desalted before analysis.  
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4.28    AMINO ACID ANALYSIS  
Amino acid analysis was performed by an adjusted protocol which depends on the 
protocols of GRACE and Agilent. The cell wall of the rodA-mutant the S. carnosus wild 
type TM300 and the S. aureus SA113 wild type was isolated after 24 h (Bertsche, U. 
et al., 2013). The lyophilized cell wall was hydrolyzed by adding 600 µl 6 N HCl to 45 
mg substrate and incubated by 110°C for at least 18 h. The released amino acids were 
then neutralized for 72 h in NaOH atmosphere under vacuum conditions. OPA 
derivatisation was performed in the injection-needle of the HPLC (Agilent 1200) as pre-
column derivatisation. Ortho-Phthaldialdehyde (OPA) was purchased from GRACE 
Davison. The stock solution of 10 mg /ml was diluted 1:10 in 1 M Borate-buffer (61.8 g 
borate in 1 liter of HPLC-grade-water). 6 µl OPA and 1.5 µl substrate were mixed for 
90 sec in the injection needle and then separated via HPLC with an Agilent 1200 series 
HPLC-system using a Grom-SIL OPA-3 (5µm) 4.0 x 150 mm column. The gradient 
was run in 24 min from 100% buffer A (25 mM Sodium-phosphate buffer with pH =7.2) 
to 100% buffer B (50% 25 mM sodium-phosphate buffer, pH =7.2, 35% methanol, and 
15% acetonitrile) in a stepwise manner. The column temperature was 25°C and the 
flow rate was 1.1 ml min-1. Absorption at 340 nm was detected and the data was 
analyzed with the ChemStation software. 
 
4.29    MICROSCOPY 
4.29.1 LABELLING OF ACTIVE PG SYNTHESIS SITES.  
(Turner et al., 2010) 
To analyze the sites of active peptidoglycan biosynthesis the cells were grown over 
night in 10 ml BHI-Medium (Brain-Heart-Infusion) containing 0.125 M D-serine. Then 
the cells were diluted into the same medium to an OD578 0.01 and grow to an OD578 
between 0.3 and 0.4. Cells were centrifuged at 5000 rpm for 10 minutes and 
resuspended in 50 ml BHI (without D-serine) and afterwards grown for 25 min (pulse) 
before D-serine was added (chase). 1 ml Samples were taken every 15 min, washed 
with 0.5 ml PBS pH 7.8 and labelled with a mixture of fluorescent vancomycin (Van-
FL) and vancomycin 1:1 to 1 µg/ml. By this method only newly synthesized 
peptidoglycan should be labeled, because of the old one being protected against 
vancomycin by the incorporation of D-Serine instead of D-Alanine. 
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4.29.2 DELTA-VISION AND FLUORESCENCE MICROSCOPY 
Cells were incubated first with D-Serine, washed and incubated without D-Serine and 
finally labeled with vancomycin FITC as fluorescence dye (4.29.1). Subsequently, 200 
µl cells were spun down by centrifugation and were washed three times in 1 ml PBS. 
All centrifugation steps were carried out in 1.5 ml ERT’s at 6’000 rpm for 5 min at RT 
From the 200 μl PBS dissolved cell solution 10 μl were transferred to agarose coated 
slides (1% (w/v) of agarose was dissolved in 1x TAE and 1 ml was applied to dust-free 
glass slides). The location of the peptidoglycan biosynthesis of S. carnosus was 
determined by fluorescence microscopy. The slides were analyzed by fluorescence 
microscopy (Leica Dm 5500 B, Camera DFC 360 Fx). Alternatively, the samples were 
analyzed by a delta-vision microscope. The advantage of a deltavision microscope is 
the possibility of the deconvolution. Deconvolution is a software-based process by 
which one can "re-focus" an out of focus image. Deconvolution occurs after image 
acquisition, and uses nearest-neighbor algorithms to extract information out of blurred 
regions of an image to clean up these regions - they then appear to be closer to, if not 
actually in the same plane of focus as the rest of the image.  
 
4.29.3 TRANSMISSION ELECTRON MICROSCOPY 
For closer examination of the cell surface and the division planes TEM was used. 
Exponentially grown cells were resuspended at 37°C in 6 ml PBS at OD578 of 0.5 at 
578 nm where cells gradually start to autolyse; 2 ml samples were taken at time points 
of 0, 2 and 4 h. Samples were processed for TEM as described previously (Biswas et 
al., 2006). Brieﬂy, bacterial cells in the stationary phase were harvested and washed 
twice with 100 mM phosphate buffer (pH 7.0). Cells were ﬁxed using the 
glutaraldehyde/OsO4 method. Fixed cells were covered with 2% agarose and blocks 
were cut out. After washing, agar blocks were dehydrated in an ethanol series 
beginning with 50% ethanol and ﬁnally placed in water-free acetone. Samples were 
then embedded in Spurr’s resin and polymerized at 60°C for 2 days. Ultrathin sections 
were cut with an ultramicrotome with a diamond knife.  
Samples were poststained with 1% uranyl acetate for 1 h and Reynold’s lead citrate 
for 20 min and examined with a Zeiss EM 109 transmission or a Philips CM10 electron 
microscope electron microscope at 80 kV.  
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4.30    STROM 
4.30.1.1 STROM working principle 
STORM is a super-resolution imaging technique that utilize sequential activation and 
time-resolved localization of photoswitchable fluorophores to create high resolution 
images. The fundamental principle behind stochastic optical reconstruction microscopy 
(STORM) is that the activated state of a photoswitchable molecule must lead to the 
consecutive emission of sufficient photons to enable precise localization before it 
enters a dark state or becomes deactivated by photobleaching. Additionally, the 
sparsely activated fluorescent molecules must be separated by a distance that 
exceeds the Abbe diffraction limit (in effect, greater than approximately  
250 nanometers) to enable the parallel recording of many individual emitters, each 
having a distinct set of coordinates in the lateral image plane.  
 
4.30.1.2 STORM sample preparation 
For preparation of the samples with Gold Fiducial Particles 103 nm gold nanoparticle 
were vortexed until particles were fully suspended. 5 µl of 103 nm gold nanoparticle 
suspension were added to 95 µl water (HPLC grade). The suspension was briefly 
vortexed again. 5 µl of this suspension were put onto a Poly-L-Lysine coated slide and 
dried with nitrogen. Bacterial cells were added from the suspension samples after Van-
FL labeling (4.29.1) in the same way. No washing step is required. The samples were 
transferred to the STROM and analyzed for 1 h. Gold particles are fixing points for the 
imagine software and work as drift correction during the STORM observation time 
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5 AIM 
In the coccal organism S. carnosus there are genes annotated for three SEDS-family 
proteins (rodA, ftsW1, and ftsW2). RodA is responsible for cell elongation in rod-
shaped bacteria while FtsW is part of the divisome. The elucidation of the role of these 
proteins in a coccal organism has been the major goal of this study; especially because 
S. carnosus cells are true cocci lacking an elongation growth phase. Therefore, 
construction of the deletion mutants for all three genes was planned and performed. 
These mutants should be characterized regarding obvious phenotypes which can give 
insights in the protein/gene function. In the beginning growth experiments were 
performed to decide if the deletion had a general effect on the fitness of the cells. To 
test an effect on the cell shape simple microscopy studies followed. Detailed insights 
were gained by intensifying these studies with fluorescence techniques, super 
resolution microscopy and electron microscopy. 
The cell wall was the focus of the biochemical characterization of the mutants. 
Therefore HPLC analysis of the isolated muropeptides was performed. The general 
pattern was compared and divergent peaks were further analyzed by mass 
spectrometry. 
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6 RESULTS 
6.1 CONSTRUCTION OF THE KNOCK-OUT MUTANTS. 
To investigate the role of a gene with unknown function the common approach is to 
create a loss of function mutant and to analyze the phenotype of this mutant. Therefore, 
a gene replacement for all 3 annotated SEDS proteins in S. carnosus was planned. An 
overview of the gene organization is given in Fig. 9. 
 
 
 
Figure 9: Location of the three SEDS proteins in S. carnosus TM300 
This is an overview of the three SEDS gene containing regions of S. carnosus TM300. The 
genes Sca_1584 (rodA) (A), Sca_0739 (ftsW1) (B) and Sca_2449 (ftsW2) (C) are marked and 
their neighboring genes are displayed.  
 
 
The knock-out procedure itself was performed following the protocol for allelic 
replacement (Brückner, 1997). Thereby the rodA gene was replaced by an aphAIII-
cassette resulting in Kanamycin resistance of the mutant. To receive a clear knock-out 
mutant the kanamycin resistance cassette was excised by the cre-recombinase 
(Leibig, M. et al., 2008), which was introduced into S. carnosus ΔrodA. After recognition 
of the lox 66 and lox 71 sites, the recombinase cuts out the DNA region between these 
two sites resulting in an marker less mutant and a lox 72 site, which itself is a poor 
substrate for the cre-recombinase enabling construction of a double mutant by the 
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C
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same technique (Leibig, Martina et al., 2008). All three genes could be successfully 
deleted as single mutants. However, a double mutant could not be created 
independent of the combination tested. 
 
6.2 VERIFICATION OF GENE DELETIONS BY PCR 
Growth on kanamycin containing plates indicates that the aphAIII cassette is working 
while growth on chlorampenicol indicates that the pBT2 plasmid containing the 
chloramphenicol resistance is still present in the cells. Therefore a clone that grows on 
kanamycin but does not grow on chlorampenicol should have integrated the aphAIII 
cassette into the genome and lost the plasmid. To verify the deletions the genomic 
DNA of one or more clones was isolated. The verification was done before the cre-
recombinase was introduced to create marker less mutations. To test the genomic 
DNA PCR was performed. Primers to amplify the gene of interest (which should have 
been replaced by the aphAIII cassette), primers for the aphAIII cassette as well as 
primer for a third gene locus at a different and distant site were used. For control issues 
TM300 WT DNA and different plasmids were used as template.  
 
RodA 
 
Figure 10: Verification of the ∆rodA::aphIII deletion mutant in S. carnosus:  
Deletion of rodA was verified by PCR using the respective genomic DNAs or plasmid pBT2 
rodA as template. The rodA gene was lost in the mutant. Instead the aphA III cassette could 
be amplified from this genomic DNA. The upper row indicates the amplicons which were 
expected by using the respective primers. The second row displays the template DNA used. 
The marker is a 1Kb letter from Fermentas. 
 
In the case of the ∆rodA mutant primers for rodA, ftsW2 and the aph-cassette were 
used. The genomic DNA of the mutant clone (∆rodA) resulted in no amplification of 
Primer rodA ftsW2 aphIII Primer
M ∆rodA WT ∆rodA WT WT ∆rodA pBT2 
rodA
M
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rodA but with the wild type DNA there was an amplicon with the expected size of 
approximately 1400 bp. With the primers for ftsW2 an amplicon of the correct size from 
both templates was achieved. As expected the aphAIII-cassette could be amplified 
from the rodA mutant but not from the wild type. To add an additional control here the 
pBT2 knock out vector was also used as a template for the amplification of the aph-
cassette, which gave a positive result. Additionally, plasmid isolation was performed 
with the selected clones but no plasmid could be obtained, proofing that the plasmid 
was lost. 
 
FtsW1 
In the case of ftsW1 the mutant was also verified by PCR using the genomic DNA of a 
mutant and a wild type clone as well as plasmid DNA to control the reaction. Here it 
was renounced to use primers for a third distant locus. The PCR for ftsW1 gave an 
amplicon with the wild type DNA as template and none for the mutant DNA, while the 
control with a pJet plasmid containing fstW1 was also positive. aphIII could be amplified 
from the mutant DNA and the pBT2 ftsW1 knock vector as template, while there was 
no amplicon with the genomic wild type DNA 
 
Figure 11: Verification of the ∆ftsW1::aphIII deletion mutant in S. carnosus:  
EtBr stained 1% agarose gel demonstrating the deletion of ftsW1. The upper lane indicates 
the amplicons which were expected by using the respective primers. The second lane displays 
the template DNA used. The marker is a 1Kb letter from Fermentas. 
 
 
  
Primer ftsW1 aphIII Primer
M ∆ftsW1 pJET
ftsW1
WT M pBT2 
rodA
WT ∆ftsW1 M
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FtsW2 
The DNA was tested with primers for ftsW2 and aphIII respectively. The PCR for ftsW2 
gave an amplicon with the wild type DNA as template and none for the mutant DNA 
while the control with a pJet plasmid containing fstW2 was also positive. aphIII could 
be amplified from the mutant DNA and the pBT2 ftsW2 knock vector as template while 
there was no amplicon with the genomic wild type DNA 
 
 
Figure 12: Verification of ∆ftsW2::aphIII deletion mutant in S. carnosus:  
EtBr stained 1% agarose gel demonstrating the deletion of ftsW2. The upper lane indicates 
the amplicons which were expected by using the respective primers. The second lane displays 
the template DNA used. The marker is a 1Kb letter from Fermentas. 
 
 
As only ∆rodA gave an obvious phenotype all further experiments described were 
performed with this mutant. A short summary on ∆ftsW1 and ∆ftsW2 is given in section 
6.9 on page 78. 
 
  
Primer ftsW2 aphIII Primer
M WT ∆ftsW2 pJET
ftsW2
M WT ∆ftsW2 pBT2 
rodA
M
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6.3 VERIFICATION OF THE RODA MUTANT 
6.3.1 STRAIN TYPING BY PCR 
To further verify the ∆rodA mutant as an S. carnosus TM300 PCR was performed with 
various primer pairs (Kull, 2009) to discriminate different staphylococcal strains from 
one another. The selected genes are listed in Tab. 16. Only when S. carnosus subsp. 
carnosus or S. carnosus subsp. utilis have been used as template all of the primer 
pairs could produce an amplicon. In different staphylococcal species only some 
amplicons would be detected. For example Sca_2051 is also detectable in S. 
gallinarum DSM 20610T and S. sciuri subsp. sciuri DSM 20345T or Sca_0076 in S. 
haemolyticus CCM 2737T and S. lugdunensis ATCC 43809T. The results of S. 
carnosus TM300 Wt and S. carnosus TM300 ∆rodA were compared. In the both cases 
all 5 primer pairs produced an amplicon with the specific size (Figure 13) and therefore 
the rodA deletion mutant was identified as derived from S. carnosus TM300.  
 
Tab. 16: Target genes picked for verification of a strain as S. carnosus TM300  
 
Figure 13: Specific PCR products to verify S. carnosus species:  
Comparison of S. carnosus TM300 and S. carnosus TM300 ∆rodA::lox72. PCR products with 
same size in both strains show that S. carnosus TM300 ∆rodA::lox72 is indeed derived from 
S. carnosus TM300.  
Gene Size (bp) Annotation 
Sca_0076   1146 putative oxidoreductase 
Sca_0079 843 hypothetical protein 
Sca_0909 1311 putative membrane protein 
Sca_2051 1266 conserved hypothetical protein 
Sca_2158 912 putative UDP-Glucose 4-Epimerase 
Sca_0079 Sca_2158 Sca_0076 Sca_2051 Sca_0909
M Wt rodA Wt rodA Wt rodA Wt rodA Wt rodA M
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6.4 SEQUENCING OF 16S RRNA LOCUS 
To further identify the mutant strain as a deletion of rodA in the S. carnosus TM300 the 
genetical background was verified by an analysis of the 16S ribosomal RNA. The 16S 
rDNA sequence is a gene encoding small subunit ribosomal RNA. This gene contains 
conserved sequences of DNA common to all bacteria and divergent sequences unique 
to each species of bacteria. Primer were constructed that could amplify the DNA locus 
of the 16S ribosomal RNA of various bacterial species such as Listeria, Bacteroides, 
Mycobacteria, Clostridia, Corynebacteria, Pseudomonas, Staphylococcus, 
Escherichia, Streptococcus and more. These so called Universal Primers (Tab. 5) were 
used to amplify these approximately 1500 bp from the WT and the ∆rodA mutant, which 
were then cloned into the pJet cloning vector and finally sequenced. The revealed gene 
sequences were blasted. First hit in both cases was S. carnosus TM300 16S rRNA. 
The next possible candidate already contained 3 nucleotide exchanges within the first 
1000 bp which could not be found in the amplified regions. Therefore the ∆rodA mutant 
is definitely an offspring of S. carnosus TM300. 
 
6.5 CHARACTERIZATION OF THE RODA DELETION MUTANT 
6.5.1 DELETION OF RODA FROM S. CARNOSUS TM300 AFFECTS GROWTH 
To study the role of the SEDS proteins in S. carnosus growth experiments were 
performed. As the SEDS proteins are thought to be part of the cell division machinery 
one would expect the deletions to influence growth. 
Deletion of rodA generated a viable S. carnosus strain with a reduced growth rate 
compared to the wild type S. carnosus TM300 (Figure 14). This indicated that RodA 
plays indeed a role during cell proliferation of staphylococci. Complementation (compl.) 
of this mutant by the expression of the rodA gene from the xylose (xyl) inducible 
plasmid pCX31 (Wieland et al., 1995) demonstrated that rodA deletion was causative 
for the observed growth defect. The ∆rodA mutant strain had a shortened lag phase 
compared to the wild type strain, but then growth slowed down after about 4 hours. 
This could also be seen when the cells were dilution plated on agar. After 3 hours the 
∆rodA mutant grew in thick patches up to a dilution of 10-5 while the wild type strain 
and the complemented mutant grew in single colonies already at the 10-4 dilution. At 
time point 5 hours, the picture was conversed. The ∆rodA mutant only grew until 10-4 
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while the other two strains formed colonies up to 10-6. This reduction in cell amount 
indicates that part of the ∆rodA mutant cells died. After 8 hours, there were still about 
ten times more viable cells of the wild type strain and of the complemented mutant than 
of the ∆rodA mutant, which reflected the situation in liquid culture. In contrast to the 
mutant the wild type strain had a real lag-phase and therefore began to grow slower 
than the mutant. After the transition to the exponential phase the wild type grew 
stronger until both strains reached an equal according to the OD at about 5 hours from 
start. From this time point on the wild type surpassed the mutant in OD and reached a 
higher maximum OD value than the mutant. The CFU determination showed that there 
was no detectable lysis during the growth experiment for the wild type.  
Repression of the complementation plasmid by 0.5% glucose resulted in a strain 
mimicking the growth of the mutant strain, albeit with a higher OD value at the end. 
When complementation was induced by 0.5% xylose, the mutant strain grew like the 
wildtype parent. Induction of the RodA protein to complement the mutant restored the 
growth to wild type level also for the early stages. In the exponential phase the induced 
complementation ascended as steeply as the wild type but the maximum OD value 
was slightly lower than that of the wild type. This was also observed in the CFU 
determination in the late stages of the growth experiment, where the CFU is not quite 
on wild type level. 
 
 
Figure 14: Growth curve and CFU-determination  
(A) S. carnosus TM300 and ΔrodA mutant cells were grown in liquid B-medium without 
glucose. The OD578 was measured every 60 minutes. (B) After 3, 5 and 8 hours the CFU was 
determined on solid B-medium.  
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6.5.2 THE RODA MUTANT IS MORE PRONE TO LYSIS 
By chance I observed that the ∆rodA mutant formed clusters when incubated without 
shaking. To test this under defined conditions, cells were grown over night in 50 ml 
flasks filled with BM at 37°C shaking at 130 rpm. After the first incubation the cell 
suspensions were further incubated at room temperature on a bench for another night 
without shaking. After 48 h of incubation the ΔrodA mutant cells tended to clustering 
whereas in the wild type strain and in the complemented mutant this was deferred until 
72 h. Resuspending by hand would lead to a sticky slimy cell suspension of ∆rodA 
mutant cells in comparison to the wild type that would dissolved as clouds in the 
suspension. In this experiment the induced complementation did actually fully restore 
the mutant phenotype to wild type level. Addition of 10 µg/ml DNase and incubation for 
another 2 h with a short resuspension at the end disintegrated the cluster of the ∆rodA 
mutant cells again. 
 
 
Figure 15: Lysis assay 
Response of S. carnosus TM300 and ∆rodA to DNase: Cultures were grown over night at 37°C 
and then kept at room temperature for 48 h without shaking. DNase treatment was performed 
for 2 h at 37°C. Sedimented cells were resuspended before taking the picture. For the sake of 
a better result during photography cultures were transferred to 6 well plates which did not 
reflect the light as much as the flask would do 
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6.5.3 ELECTRON MICROSCOPICAL ANALYSIS 
To examine, whether the deletion of rodA affects the morphology of the cells several 
microscopical analysis were performed. By using light microscopy there were no 
detectable differences in shape or size. Therefore electron microscopy experiments of 
log cells were performed by York Stierhoff at the ZMBP Tübingen. Again there were 
no differences in size or shape. Also the division planes did not seemed to be altered 
in position or form. There were minor differences in the surface but it was not 
convincing to a point that it could be stated as a new phenotype for the mutant. 
 
 
Figure 16: TEM pictures 
Pictures were taken of S. carnosus TM300 WT, ∆rodA::lox72 and the complemented mutant 
in induced as well as in repressed state. 
 
6.5.4 SITES OF ACTIVE PEPTIDOGLYCAN SYNTHESIS 
The growth experiments and the observed lysis suggested an effect of the rodA 
deletion on the peptidoglycan (PG) of S. carnosus. To determine the sites of active PG 
synthesis cells were fed with D-Serine to incorporate it into the cell wall precursors at 
position 5 instead of D-ala. This prevents vancomycin binding to this very sites and 
allows for a labeling of newly synthesized peptidoglycan by a pulse chase method 
followed by FITC vancomycin (Van-FL) addition. 
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While in the wild type strain Van-FL stained the septa and to a lower amount the cell 
walls, only weak spots of fluorescence and very faint septa were observed in the ∆rodA 
mutant (white arrow Figure 17). As expected also the glucose repressed 
complemented mutant (compl. + rep.) showed a weaker septal staining and reminded 
of the ∆rodA mutant. In contrast the complemented mutant in which the rodA gene was 
expressed by xylose showed septal staining almost at the wild type level. In all four 
conditions the cells were viable as judged by DNA labeling with RedDot, but the mutant 
strain seems to lack fresh D-Ala-D-Ala residues which are required for proper Van-FL 
staining. 
 
  
 
Figure 17: Confocal laser scanning microscopy (CLSM) pictures  
S. carnosus TM300Wt, ∆rodA and the complemented mutants (repressed and induced) were 
incubated in the presence of D-serine and then grown in medium without D-serine for 25 min 
(pulse) prior to labeling with fluorescent Vancomycin [Van-FL].The samples from time t=0 are 
shown here. As incorporation of D-serine prevents vancomycin binding, only the peptidoglycan 
synthesized during the pulse is labeled by Van-FL. In all four cases the cells are viable as 
judged by DNA labeling with RedDot. The pictures were taken by Christian Liebig from the MPI 
Tübingen. 
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Van-FL labeled cells were also investigated by delta vision microscopy under the same 
experimental conditions. Delta vision can be used for deconvolution which in principle 
is a mathematical application that is used for image restoration. Literally spoken 
making straight lines out of blurred ones. With this technique, also the ∆rodA mutant 
showed septal labeling, but the label was uneven, and often formed spots within the 
whole cell. These spots were also observed in the repressed complementation, but 
neither in wild type cells nor when complementation was induced. For these images I 
used the delta vision microscope in the laboratory of Prof. Simon Foster, Sheffield UK. 
 
 
Figure 18: Deltavision microscopy pictures  
Cells were labeled with VanFL. The pictures in the top row show only the fluorescence channel 
in the bottom row only the phase contrast channel and in the middle there is a merge of both 
channels. 
 
 
6.5.5 STROM 
To get even further insights into the localization of the peptidoglycan biosynthesis I was 
able to perform another form of fluorescence microscopy named STROM (Stochastic 
Optical Reconstruction Microscopy) in the laboratory of Prof. Simon Foster (Sheffield, 
UK) together with Dr. Robert Turner. With this technique it is possible to gain an even 
higher resolution than normal light microscopy and still having the advantage of 
. 
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fluorescence. The STORM utilizes sequential activation and time resolved localization 
of photoswitchable fluorophores to create high resolution images. The goal was to 
narrow down the localization of the newly synthesized peptidoglycan and the altered 
localization in the rodA mutant as shown above. The cells were grown overnight then 
diluted in BHI medium containing 0.125 M Serine as described in the labeling method. 
Poly-lysine slides were precovered with nano-gold particles and dried with nitrogen 
gas. The cells were incubated with a Vancomycin which was linked to a specific 
fluorophore suitable for the STORM. After washing the cells were attached to poly-
lysine covered slides and dried with nitrogen. 
Unfortunately no further insights were gained by this method. The pictures confirmed 
more or less the observations from the other fluorescence microscopy experiments 
with labeled division planes in the wild type cells and accumulations of labeling at 
unspecific points of the division plane in the ∆rodA mutant cells. 
 
 
 
Figure 19: STORM (Stochastic Optical Reconstruction Microscopy)  
Pictures of S. carnosus TM300 Wt and ∆rodA::lox72: Computal reconstruction of STROM 
pictures taking of two strains labeled with VanFL according to the protocol listed above. 
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6.5.6 PEPTIDOGLYCAN ANALYSIS BY HPLC 
 
6.5.6.1 Muropeptide composition 
As SEDS proteins are potential flippases for the peptidoglycan precursor lipid II 
(Mohammadi et al., 2011) the muropeptide pattern of the wild type S. carnosus TM300 
strain, the isogenic ΔrodA mutant as well as the complemented strain were 
investigated. The muropeptide pattern of the ∆rodA mutant (red) differed from the one 
of S. carnosus TM300 WT (green). On first sight the pattern was shifted to longer 
retention times in the mutant. Additionally, peaks were not that sharp but appeared 
broad and blurred. Repression of the expression of rodA in the complementation strain 
(orange) lead to the exact same pattern as in the mutant. The complemented mutant 
(blue) is intermediate between S. carnosus TM300 and the ΔrodA mutant muropeptide 
pattern. This showed that the differences in the muropeptide pattern were indeed 
caused by the absence of RodA. 
 
 
Figure 20: HPLC analysis of peptidoglycan  
Peptidoglycan was isolated, digested by mutanolysin into muropeptides, and separated by 
HPLC. The muropeptide pattern of the ΔrodA mutant (red, ΔrodA) was altered compared to 
the wild type TM300 strain (green, TM300 WT). The complemented strain (blue, Compl. ind) 
showed an intermediate state. The repressed complementation (orange; Compl. rep) was the 
same as the mutant pattern.  
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As the muropeptide pattern of S. carnosus TM300 (WT) was different from the 
muropeptide patterns published for S. aureus strains (de Jonge et al., 1992; Bertsche, 
U. et al., 2011; Bertsche, U. et al., 2013) S. carnosus was directly compared with S. 
aureus SA113. Indeed it was observed that the muropeptide pattern of S. aureus 
(black) differed from the one of S. carnosus (green). On first sight, the ΔrodA mutant 
pattern (red) appeared to resemble S. aureus more than the one of S. carnosus. 
Therefore muropeptide peaks indicated by numbers were collected and further 
analyzed by mass spectrometry (MS).  
 
 
 
 
Figure 21: Comparison between PG of S. aureus SA113 and S. carnosus TM300.  
The patterns of S. aureus SA 113 WT, S. carnosus TM300 WT and S. carnosus TM300 ∆rodA 
were compared. The indicated peaks that were collected to be analyzed further. 
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6.5.6.2 Cross linkage 
As the ∆rodA mutant had been observed to possess a cell wall that was leakier than 
the WT, this could be caused by less cross-links formed. Therefore, cross-linkage of 
both strains was calculated from the muropeptide patterns obtained by HPLC (Figure 
21).The amount of cross-linkage in a cell wall is determined by the bonding that each 
individual muropeptide forms with their neighboring molecules. So the more 
muropeptides are bond to each other the higher is the cross-linkage. In staphylococci 
the particular bond that is formed between the non-terminal D-Ala and D-Gly of the 
adjacent interpeptide bridge. Cross linkage was calculated as follows by summing up 
½ dimers + 2/3 trimers+ 9/10 multimers (Stranden et al., 1997). The results given are 
the mean values of 5 independent experiments. 
 
Tab. 17: Crosslinkage of S. carnosus 
 
   TM300 WT ∆rodA 
Ø  80.431  79.639  
Standard diviation  0.552  0.196 
Variance 0.406  0.051  
 
The cross linkage is not different. 80.4 % is an expected value for S. carnosus TM300. 
The mutant value of 79.6 % is a bit lower, but fits quite well into the standard deviation 
of the WT. While previous experiments had suggested a weaker cell wall there was 
the possibility that the cross linkage would be lower but only a marginal decrease was 
observed ( 
Figure 15: Lysis assay). 
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6.6 MASS SPECTROMETRY ANALYSIS OF PEPTIDOGLYCAN 
From the HPLC analysis it could be concluded that there is an alteration in the 
muropeptide composition of the rodA knock out strain. To further examine this, the  
major peaks from wild type S. carnosus TM300, the ΔrodA mutant and the S. aureus 
SA113 were collected and MS analysis was carried out by Andreas Kulik to determine 
the masses of the major molecules present in each peak. It turned out, that the 
muropeptide pattern of S. carnosus widely differs from the one of S. aureus. Even 
peaks with similar retention times had different masses, e.g. they are different. The 
masses were compared to already published masses of S. aureus (de Jonge et al., 
1992). Indeed, masses were found that indicated an incorporation of serine into the 
peptidoglycan of the ∆rodA mutant. An overview of the found masses is given in Tab. 
19. For understanding the nomenclature seeFigure 22. 
 
 
Figure 22: Nomenclature of muropeptide molecules  
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 Tab. 18: Masses and molecules calculated by MS analysis  
∆rodA 
Mass 
determined  
Mass 
calculated  
Hypothetical 
molecule 
TM300 
WT 
Mass 
determined  
Mass 
calculated  
Hypothetical 
molecule 
SA113 
WT 
Mass 
determined  
Mass 
calculated  
Hypothetical  
molecule 
1  967,6 
967.0151 Tetra(Gln)Ala 1  882,6 882,408 Tri(Gln)Gly    
 
 
967.0151 Penta(Gln) 
2 
 1053,6 1053,468 Tri(Gln)Gly4 
1 
a 1010,6 1010,4783 Tetra(Gln)Gly2 
2 
a 1010,6 1010,4783 Tetra(Gln)Gly2  1110,6 1110,488 Tri(Gln)Gly5 b 1067,6 1067,4983 Tetra(Gln)Gly3 
b 1067,6 1067,4983 Tetra(Gln)Gly3 
3 
a 1111,6 1111,4723 Tri(Glu)Gly5 
2 
a 1238,7 
1238,5626 
Tetra(Gln)Gly6 
c 1211,7 1211,5597 Tetra(Gln)SerGly4 b 1238,7 1238,5626 Tetra(Gln)Gly6  
3 
a 1182,7 1182,5252 Tetra(Glu)Gly5 c 1295,8 1295,5841 Tetra(Gln)Gly7 b 1295,8 1295,5841 Tetra(Gln)Gly7 
b 1325,8 1325,600 Tetra(Gln)SerGly6 d 1352,8 1352,604 Tetra(Gln)Gly8 
3  1352,8 1352,604 Tetra(Gln)Gly8 
4  1024,6 
1024.0669 Tetra(Gln)AlaGly 
4  1181,6 
 
1181,5412 Tetra(Gln)Gly5 
1024.0669 Penta(Gln)Gly 
5 
a 1025,6 
1025.0517 Penta(Glu)Gly 5  1252,8 1252,5768 Penta(Gln)Gly5 
4  1024,6 
 
Penta(Gln)Gly 1025.0517 Tetra(Glu)AlaGly      1024,4939 
b 1182,6 1182,5252 Tetra(Glu)Gly5       
c 1081,6 1081,5139 Penta(Gln)Gly2      5  1252,8 1252,5768 Penta(Gln)Gly5 
d 1168,7 1168,554 
Penta(Gln)Ser 
Gly2 
   
 
      
e 1211,7 1211,5597 Tetra(Gln)SerGly4    
 
      
f 
1282,7 
1282,594 
Penta(Gln)SerGly
4 
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6.7 MAXIS MS-ANALYSIS 
Serine incorporation into the peptidoglycan stem peptide caused by a deletion mutant 
should be treated carefully, so it was decided to further verify the masses with a more 
sensitive MS-method which would also gave away the sum formula of the molecule. 
This analysis was performed by Luise Hoffmann of the AK Grond, Chemistry 
department. 
 
Table 20: Mass and sum formula of muropeptides analyzed by MaXis 
Monomer TM300 WT 
pos. mode 
Rt = 45.0 min, m/z 
Ion formula 
Accuracy in ppm 
 ∆rodA mutant 
pos. mode 
Rt = 51.6 min, m/z 
Ion formula 
Accuracy in ppm 
Tri(Gln)Gly5 
1111.5092 = [M+H]+ 
cal 
556.2590 = [M+2H]2+ 
cal 
567.2488 = [M+H+Na]2+ 
cal 
[C43H75N12O22]+ 
1.9 ppm  
 
0.5 ppm 
 
Penta(Gln)SerGly4 
1283.5955+ = [M+H]+ 
cal. 1283.5961 
642.30252+ [M+2H]2+ 
cal. 642.3017 
653.2923 = [M+H+Na]2+ 
cal. 653.2927 
[C50H87N14O25]+ 
0.5 ppm 
 
1.3 ppm 
 
0.6 ppm 
1133.4889 = [M+Na]+ 
cal 
 
3.9 ppm 
(low intensity) 
1305.5732 = [M+Na]+ 
cal. 1305.5781 
664,2827 = [M+2 Na]2+ 
cal. 664.2836 
3.7 ppm 
(low intensity) 
1.4 ppm 
  Penta(Gln)Ser2Gly3 
1313.6043 = [M+H]+ 
cal. 1313.6067 
1335.5841 = [M+Na]+ 
cal. 1335,5886 
657.3071 = [M+2H]2+ 
cal. 657.3070 
668,2970 = [M+H+Na]2+ 
cal. 668.2980 
679,2874 = [M+2 Na]2+ 
cal. 679.2889 
[C51H89N14O26]+ 
1.8 ppm, 
 
3.4 ppm  
(low intensity) 
0.2 ppm 
 
1.4 ppm 
 
2.3 ppm  
(low intensity) 
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Three different molecules could be identified with great accuracy. Tri(Gln)Gly5 for the 
major monomer peak of the S. carnosus TM300 WT was found and two masses from 
the major monomer peak of the ∆rodA mutant were identified as Penta(Gln)SerGly4 
and Penta(Gln)Ser2Gly3. The identification of the muropeptides that were containing 
serine was successful for the ∆rodA mutant. There was no mass detectable in the WT 
strain that could possibly contain serine.  
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6.8 AMINO ACID REACTION 
To determine the amino acid composition of the peptidoglycan the CW of the strains 
S. carnosus TM300 Wt, S. carnosus ∆rodA and the S. aureus SA113 was isolated at 
OD 0,7. By preparative HPLC the cell wall fractions were divided into three parts; a 
monomeric, a dimeric and a multimeric fraction. The lyophilized CW was hydrolyzed 
by adding HCl. For detection OPA (ortho-phthal aldehyde) derivatisation was 
performed in the injection-needle of the HPLC as pre-column derivatisation. The amino 
acids of the peptide and the interpeptide bridge could be determined both quantitatively 
and qualitatively by the height of the peaks and their retention time compared to a 
standard. A commercial available standard by GRACE containing 18 different amino 
acids was used and a self-made standard only containing the five amino acids glutamic 
acid, serine, glycine, alanine and lysine was also prepared. 
 
 
Figure 23: Standard of the amino acid reaction with OPA:  
Commercial and self-made standard of the amino acid after pre-column derivatisation with 
ortho-phthalaldehyde and separation via HPLC. The commercial available standard (blue) 
contained 18 different amino acids while the self-made standard (red) only contained five 
amino acids which were thought to be present in the peptidoglycan. In the upper left blue box 
the structure of OPA is shown. 
  
100 mAu
Lysin
Glutamic acid
Glycin
Serin
Alanin
ortho-phthal
aldehyde
min5 10 15 20 25
76 
 
6.8.1 AMINO ACID COMPOSITION OF THE PEPTIDOGLYCAN 
As calculated from the MS analysis data the ΔrodA mutant contained muropeptides 
which carry serine in their peptide moiety and several of them lacked the amidated 
glutamate at position two of the stem peptide. The peptide moiety of the muropeptides 
was hydrolysed and the amino acid composition was determined by HPLC using 
precolumn derivatization by ortho-phthaldialdehyd (OPA). By this method it is not 
possible to distinguish between glutamate and glutamine, as the latter loses its amino 
group during hydrolysis. The retention times of the found amino acids were very 
different, so they could be easily identified by comparison to the self-made standard. 
  
 
 
Figure 24: Amino acid analysis of the different fractions of the mutanolysin digested 
peptidoglycan :  
S. carnosus TM300 WT (green) and ∆rodA mutant (red) as well as S. aureus SA 113 WT (pink) 
peptidoglycan was isolated and digested with mutanolysin and separated via HPLC. (A) 
Monomeric, (B) dimeric and (C) tri/tetrameric fractions were isolated and an amino acid 
reaction was performed with every single fraction.  
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The amount of each amino acid was calculated in comparison to glutamate/ine (called 
Glx), which was set to 1.0 (Tab. 19 ). In S. aureus WT serine was not found and S. 
carnosus WT the amino acid serine was found but only in small amount. However, the 
amount of serine in the ΔrodA mutant was increased by 250% compared to S. 
carnosus TM300. This was also reflected by a concomitant decrease of glycine, 
suggesting that serine is incorporated into the interpeptide bridge.  
 
Tab. 19: Amino acid distribution per strain and peptidoglycan fraction 
The amount of each amino acid was calculated in comparison to Glx (can stand for glutamic 
acid or glutamine) which was set to 1. The average amount was calculated from all three 
fractions. 
 
 
 
 
 
  
Amount Ø Amount Ø Amount Ø Amount Ø Amount Ø Amount Ø
Mono 1.0 0.1 5.4 4.7 2.0 0.7
Di 1.0 0.2 6.8 0.1 2.9 1.0
Tri-Tet 1.0 0.2 5.7 2.5 2.3 0.9
Mono 1.0 0.0 5.7 8.9 1.7 1.4
Di 1.0 0.4 5.1 0.8 2.0 0.9
Tri-Tet 1.0 0.0 6.5 0.1 2.2 0.9
Mono 1.0 0.5 4.4 6.1 2.4 0.9
Di 1.0 0.8 4.6 1.7 2.4 0.9
Tri-Tet 1.0 0.9 6.1 0.1 3.2 1.1
2.7 0.9ΔrodA 1.0 0.7 5.0 2.6
2.4 0.9
TM300 1.0 0.2 5.7 3.3 2.0 1.0
SA113 1.0 0.2 6.0 2.4
LysineGlx Serine Glycine L-Alanine D-Alanine
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6.9 SUMMARY OF THE  ∆FTSW1 AND∆ FTSW2 MUTANTS  
The gene replacements of ftsW1 and ftsW2 respectively were examined concerning 
growth (Fig.: 25) and muropeptide pattern (Fig.:26). Differences to the wild-type S. 
carnosus TM300 could not be observed but however to the ∆rodA mutant. 
 
Figure 25: Growth curve SEDS single mutants and Wild type 
S. carnosus TM300 WT and all three single mutants of the SEDS proteins were compared 
concerning growth. WT (green), ∆ftsW1 (yellow) and ∆fstW2 (brown) showed a very similar 
growth rate while the ∆rodA (red) mutant differed in the beginning as well as at the end. 
 
 
 
Figure 26: HPLC analysis of all SEDS mutant strains 
The muropeptide pattern of the three SEDS protein single mutant strains was compared by 
HPLC. The mutant strains of ftsW1 (yellow) and ftsW2 (brown) did not show any differences 
to the wild type strain (green). As comparison the altered muropeptide pattern of the ∆rodA 
mutant (red) is displayed. 
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7 DISCUSSION 
 
7.1 SEDS PROTEINS 
The abbreviation SEDS stands for Shape Elongation Division and Sporulation. 
Proteins associated with this family share sequential and functional similarity. They are 
integral membrane proteins that are present in all cell wall-containing bacteria (Ikeda 
et al., 1989) and are highly conserved. So far their function was elucidated by 
mutations affecting cell shape, e.g. turning rods into spheres (rod mutations) (Begg 
and Donachie, 1985) or filament formation.  
In several organisms the SEDS protein encoding genes are co-localized on the 
chromosome with a gene for a monofunctional PBP. Using KEGG (Kyoto Encyclopedia 
of Genes and Genomes) the chromosomal organization of several frequently used 
research organisms as well as of all staphylococcal strains sequenced so far was 
checked. In Escherichia coli K-12 MG1655, in Caulobacter crescentus NA1000, in 
Mycobacterium tuberculosum H37Rv as well as in Corynebacterium glutamicum ATCC 
13032 (Bielefeld) there is indeed a co-localization of the gene for the SEDS-protein 
FtsW with the cell division specific penicillin-binding protein FtsI (PBP3) and the cell 
wall synthesis proteins MraY and MurG. In addition, in all these strains the RodA gene 
is a direct neighbor of a PBP gene. However, in Bacillus subtilis 168 while there is a 
co-localization of the gene for the SEDS protein SpoVE with the ones for PBP2B and 
SpoVD (two PBPs), MraY, and MurG, none of the other seven synthesizing PBP genes 
is a neighbor of the RodA gene. In Streptococcus pneumonia (R6) as well as in all 
Staphylococcus strains whose sequence is available so far, none of the SEDS protein 
genes is in the vicinity of a PBP gene. But in all staphylococcal genomes checked, 
mraY was always located near a pbp gene (one to seven genes apart).  
In principle, one SEDS gene should be enough for a coccoidal bacterium to survive, 
and in S. aureus rodA is considered as non-essential (Chaudhuri et al., 2009). 
However, so far a rodA deletion mutant in S. aureus SA113 could not be created.  
S. warneri a recently sequenced and annotated staphylococcal strain was checked for 
rodA and only a truncated variant of rodA was found (Cheng et al., 2013). But with the 
first 4 transmembrane domains missing the protein should not be functional, according 
to (Mohammadi et al., 2014) . With six out of ten transmembrane domains still there 
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and the big extracellular loop still existing the fundamental function of the protein could 
very well still be intact but according to recent studies (Mohammadi et al., 2014) it is 
most likely not, because the missing domains seems to the domains important for the 
flipping function at least for the FtsW of E. coli. 
E. coli as well as other kinds of bacteria encodes a closely related pair of specialized 
proteins-PBP3 and FtsW - that function in cell division. In E. coli the activities of these 
two dual-gene systems appear to alternate. The RodA/PBP2 system dominates in 
case of elongation growth. When cell division appears the FtsW/PBP3 system comes 
into play (Daniel and Errington, 2003). Growth and division works differently in 
staphylococci so it is not remarkable that they are no known dual-gene systems. All 
the more so since not only one but three different SEDS-proteins were found in S. 
carnosus while all other sequenced staphylococcal strains possess only two variants, 
one copy for fstW and one for rodA. Bacteria of the genus Staphyloccus divide in a 90° 
angle. They do not undergo elongational growth. They do not sporulate and their shape 
as cocci cannot be changed as it is the simplest form generally (Lleo et al., 1990). With 
three out of four aspects of the SEDS proteins not applying for staphylococci we 
expected an influence on growth by division if we disabled one or more SEDS proteins. 
Recently FtsW was identified as the Lipid II flippase for E. coli (Mohammadi et al., 
2011). However, the knock-out mutants created in both of the ftsW loci of  
S. carnosus did not show any phenotype at all leading to the suggestion that the loss 
of one copy can be complemented by the other one or by rodA. Only deletion of rodA 
resulted in a mutant with an obvious phenotype. As we were unable to generate double 
mutants of the SEDS proteins in any combination possible it is tempting to conclude 
that although non-essential on their own at least two functional SEDS proteins are 
necessary for the viability of S. carnosus. One could envision, that the two SEDS 
proteins take turns in defining the next division plane. 
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7.2 EFFECTS OF THE RODA DELETION ON GROWTH AND VIABILITY 
The deletion of rodA in S. carnosus created a viable mutant showing a distinct 
phenotype. First to notice was a growth defect, which was expected from the theory of 
SEDS proteins. Being a potential flippase for Lipid II it is astonishing that the mutant 
almost completely skipped the lag phase but started to grow faster in the beginning. 
With no clear explanation to this observation one could take into consideration that 
whatever protein it is that takes over the function of RodA during growth is produced 
differently whether due to an increased expression in the absence of rodA or a different 
pattern in terms of time and growth phase in general. After 4 to 6 hours of growth the 
OD of both strains was the same. During further growth the wild type strain passed the 
OD values of the mutant ending up significantly higher. To have a closer look dilution 
series were plated during the growth which revealed that the declined OD might be 
due more to dying mutant cells than slowed down growth, because already at a time 
point when the OD of both strains was about equal (5 h) the wild type formed colonies 
with a dilution of a factor ten higher than the mutant. This discrepancy even grew as 
time progressed (Figure 14: Growth curve and CFU-determination). While it is not 
obvious why the mutant grew stronger than the wild type during the early growth phase 
the decreased CFU explained the decline during the mid and late exponential phase. 
The CFU decrease was not seen when the mutant strain was complemented by the 
expression of rodA.  
To complement the deletion of rodA the low copy vector pCX was used to control the 
expression of the gene by adding sugars to the medium (Wieland et al., 1995). Xylose 
induces the expression while glucose blocks it due to the effects of the catabolite 
repression. Despite all the expression control the complementation did not fully restore 
the growth to wild type level in stationary phase nor did the repressed rodA expression 
mimic the mutant phenotype exactly, but an effect in both ways was clearly observable. 
Especially the reduced lag phase of the mutant was also present when rodA 
expression was repressed. In contrary this was not observed anymore when gene 
expression was induced by xylose. An incomplete repression is not uncommon in these 
kinds of scenarios and most likely due to the vector still being leaky to some extent. 
On the other side the induction also does not seems to be complete. The reason could 
be a simple gene-doses effect because the number of copies is not the same as in a 
wild type situation. A more complicated regulation mechanism working in cis or a 
regulatory element the plasmid is lacking are further possible explanations. 
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As it was shown by bacterial-two-hybrid experiments that rodA is a part of the 
peptidoglycan biosynthesis machinery in staphylococci it interacts with PBPs for 
example. The stability of the cell wall could be influenced by its absence whether RodA 
is acting one of the Lipid II flippases or interaction partner for other enzymes crucial for 
peptidoglycan biosynthesis (Deibert, 2011; Steele et al., 2011; Hoovestadt, 2014). 
7.3 INSTABLE RODA MUTANT CELLS 
According to the growth curve and CFU experiments it could be shown that the mutant 
did lyse earlier than the wild type. This was also observed in incubation flasks, when a 
culture of both strains was held at room temperature for more than 48 h without shaking 
( 
Figure 15). The cells sedimented at the bottom and the medium became clearer. Upon 
resuspension by hand the wild type cells floated again in the medium. The mutant cells 
instead formed of viscous phlegm at the bottom of the flasks that could not be 
resuspended. Once observed by chance it could be repeated sequentially. A DNase 
treatment with following resuspension resolved the phlegm, indicating that the viscous 
cell mass was indeed cells clumped together in a DNA mash which leaked out of 
broken cells. For the wild type strain, this state of degeneration did also appear but 
with a delay of at least 24 h which speaks in favor of an instable cell wall of the mutant 
cells and a natural reaction of dying cells instead of an increased autolysis which would 
be resolved faster (Tobin et al., 1994). Because the DNase treatment was able to 
dissolve the cell mass it is sure, that the clumps are no kind of biofilm formation (which 
does not exist in S. carnosus) or other sticky meshwork, but are the product of DNA 
leaking out of the cells. 
 
7.4 LOCALISATION OF PEPTIDOGLYCAN BIOSYNTHESIS 
An instable cell wall could be caused by alterations of peptidoglycan (PG) biosynthesis 
during cell division. To determine sites of active peptidoglycan biosynthesis in the 
ΔrodA mutant compared to S. carnosus TM300 WT, cells were labeled with fluorescent 
vancomycin [Van-FL]. In order to stain only newly synthesized peptidoglycan, cells 
were grown in the presence of D-serine, which is incorporated instead of D-alanine on 
position five of the stem peptide and prevents binding of Van-FL. When the cells were 
grown again without D-serine, the newly synthesized murein contained D-Ala-D-Ala 
83 
 
residues again, which got labeled by Van-FL and could by visualized by fluorescence 
microscopy.  
While in the wild type strain Van-FL stained the septa and to a lower amount the cell 
walls, only weak spots of fluorescence and very faint septa in the ΔrodA mutant were 
observed (Figure 17, Figure 18). This showed that peptidoglycan biosynthesis was 
much slower in the mutant strain than in wild type S. carnosus as less newly 
synthesized cell wall without D-serine was incorporated during the pulse. As expected 
also the glucose repressed complemented mutant showed only weak septal staining. 
In contrast the complemented mutant in which the MS analysis rodA gene was 
expressed by xylose showed septal staining almost at the wild type level. So RodA is 
clearly involved in the peptidoglycan synthesis of S. carnosus.  
A similar labeling pattern was reported for Bacillus subtilis, when grown in the presence 
of a mixture of D-amino acids, and in Bacillus subtilis cells in stationary phase (Lam et 
al., 2009). This supports the results from the amino acid analysis (see below), where 
an increase in D-Ala, which indicated stress, was found. This stress indication is also 
supported by the observed clustering of cells due to DNA webs because of an 
enhanced lysis. Taken together the ΔrodA mutant cells are under stress which affects 
the bacterial cell wall. 
 
7.5 PEPTIDOGLYCAN COMPOSITION IS ALTERED 
As all the previous experiments hinted for alterations of the cell wall, the muropeptide 
pattern of the wild type S. carnosus TM300 strain, the isogenic ΔrodA mutant as well 
as the complemented strain was investigated and compared in between the  
S. carnosus strains and to the known pattern of S. aureus (Figure 20 and Figure 21). 
It was observed that the muropeptide pattern of S. aureus differs from the one of  
S. carnosus. On first sight, the ΔrodA mutant pattern with its shifted retention times 
appeared to resemble S. aureus more than the one of S. carnosus but the peaks are 
blurred. However, MS analysis showed that even though peaks had identical retention 
times, they had different masses, i.e. they are different. The complemented mutant 
was intermediate between S. carnosus TM300 and the ΔrodA mutant. This can be 
explained either by the fact that peptidoglycan was isolated at OD578~0.7, which was 
about the time the complementation effect started and or by a gene-dosage effect that 
occured after external induction of rodA. 
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In the past the investigation of sets of different strains of cell wall antibiotic resistant 
mutants and corresponding sensitive parental strains (Bertsche, Ute et al., 2011; 
Göhring et al., 2011) have never lead to such drastic differences in the muropeptide 
pattern, indicating that lack of RodA activity (or presence) is not comparable to known 
antibiotic effects.  
 
7.6 AMINO ACID COMPOSITION OF THE PEPTIDOGLYCAN 
 
Figure 27 Variations peptide composition of peptidoglycan (Vollmer, 2012) 
 
As calculated from the MS analysis data the ΔrodA mutant contained muropeptides 
which carry serine in their peptide moiety and several of them lack the amidated 
glutamate at position two of the stem peptide. Therefore the amino acid composition 
of the peptide moieties was determined by HPLC using precolumn derivatization by 
ortho-phthaldialdehyd (OPA).  
Indeed, the amount of serine in the ΔrodA mutant increased by 250% compared to 
S. carnosus TM300 WT. This was also reflected by a concomitant decrease of glycine, 
suggesting that serine is incorporated into the interpeptide bridge. As the amount of 
serine is usually underestimated (10 to 40%) by the method used this strongly indicates 
an even higher amount of serine. An amount of 0.09 serine residues per 1 Glx residue 
has been reported for S. carnosus TM300 before, meaning that a small amount of 
serine is natively incorporated into its interpeptide bridge (Thumm and Götz, 1997). 
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This indicates that Lipid II with serine is still a substrate for the murein synthesizing 
penicillin-binding proteins (PBPs), but the PBP activity seems to be slowed down. This 
could also explain, why the overall cross-linkage of the mutant is not significantly 
altered, like one would suspect by altering the substrate for the transpeptidases from 
a D-Ala-D-Ala to a D-Ala-D-Ser. In the VRSA strain Mu50 the amounts of glutamine-
non-amidated muropeptides were increased and a decreased cross-linking of 
peptidoglycan with a greatly decreased dimer/monomer ratio of muropeptides were 
found (Hanaki et al., 1998) although in this case there is no serine incoorporation. 
The amount of glycine and L-alanine also seems to be rather high on the first sight. 
However, as peptidoglycan is constantly remodeled, glycine residues from former 
cross-links are often retained. This has already been reported twenty years ago for  
S. aureus. The same paper also shows that there is a certain amount of L-alanine 
incorporated into the glycine interpeptide bridge of S. aureus (de Jonge et al., 1992). 
In general the stem peptide composition can be quite flexible and must not only consist 
of L-Ala-D-Glx-L-Lys-D-Ala-D-Ala, indicating that the interpeptide bridge must not 
strictly consist of five glycine. In addition it was shown for the SEDS protein FtsW of  
E. coli that also the flipping mechanism can tolerate much bigger variations 
(Mohammadi et al., 2014).  
However, the increased incorporation of serine into the interpeptide bridge in the 
absence of rodA was an astonishing observation. This could be a general response to 
cell wall stress in the S. carnosus cells. The wild type cells have a small amount of 
serine in the cell wall, too. The idea that RodA provides selectivity for the flipped Lipid 
II may be ruled out on the one hand by the peptidoglycan labeling experiments, where 
also in wild type cells serine residues in the stem peptide are found only by providing 
them in the medium (working principle of the vancomycin labeling) and on the other 
hand from the earlier mentioned tolerance of the flippase activity of the FtsW protein 
(Mohammadi et al., 2014). The data of this study cannot fully explain where the serine 
residues are incorporated into the peptidoglycan whether it is instead of alanine in the 
stem peptide or instead of glycine in the interpeptide bridge. Although muropeptide 
with a full penta stem-peptide and additional serine see it incorporated in the 
interpeptide bridge, a well-known resistance mechanism against lysostaphin (Thumm 
and Götz, 1997). Therefore I propose incorporation into the interpeptide bridge, but I 
do not know which of the glycine residues are replaced 
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Regarding the shifted muropeptide pattern in Figure 20 there is a possible explanation 
given by the in depth MaXis analysis of the single major muropeptide peaks: peak 3 of 
S. carnosus TM300 and peak 5 of the ΔrodA mutant. The first mass spectrometric 
analysis that had been performedby the IonTrap method had already revealed several 
Tri-peptides in peaks 2 and 3 of wild type strain while the ΔrodA mutant peaks 
consisted of Penta- or Tetra-peptides only. With the TOF analysis of the MaXis 
instrument Tri(Gln)Gly5 could be detected with an accuracy of 0.5 ppm for peak 3 of 
the S. carnosus TM300 strain. The corresponding muropeptides in the ΔrodA mutant 
peak 5 were Penta(Gln)SerGly4 and Penta(Gln)Ser2Gly3, indicating that in the mutant 
the stem peptide gets not processed, as it was seen in the wild type. The enzyme 
responsible for this processing must be an L,D-carboxypeptidase. Carboxypeptidases 
are enzymes that can hydrolyze peptide bonds at the carboxy-terminal end of a protein 
or a peptide. There are 3 annotated carboxypeptidases in S. carnosus TM300 namely 
both pbp4 genes (Sca_0291and Sca_2445), which are both D-alanyl-D-alanine 
carboxypeptidases and therefore ruled out. And the Sca_0214 gene, an L,D-
carboxypeptidase which is yet to be examined. The only other staphylococcus known 
to possess on orthologue of this latter enzyme is  
S. pseudointermidius. One could think of an inhibition of the carboxypeptidase activity 
by the incorporated serine of the muropeptides maybe due to sterical hindrance of the 
enzyme substrate complex, resulting in unprocessed Tetra- and Penta-Muropeptides 
in the ΔrodA mutant.  
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8 CONCLUSION 
 
In general rodA deletion is possible in S. carnosus but causes cell stress, which results 
in increased lysis. The cell tries to counteract by incorporation of serine into the 
interpeptide bridge. However, the resulting serine containing muropetides are no 
longer a substrate for the L,D-carboxypeptidase, which seems to processes the 
muropeptides of the wild type S carnosus TM300 strain. In E. coli Tri-muropeptides are 
proposed to be the initiation point for cell division (Höltje, 1998). One could envision a 
similar role in S. carnosus, which would lead to cell stress when this processing is 
missing. 
With the findings in the CFU/growth and the lysis experiments it is clear that the 
increased serine incorporation does not increase the cell wall stability. Rather it seems 
that the serine turns the Lipid II into a poorer substrate for the PBPs which would 
explain the slower and dispersed biosynthesis of the peptidoglycan with a slower 
division rate and higher lysis rate and therefore a slower growth rate. While the overall 
biosynthesis of the cell might suffer from the serine incorporation the turnover 
processes of the cell are maybe still working properly resulting in a higher lysis rate of 
the mutant. 
 
It is very fascinating is how bacteria acquire, maintain, and modify their shapes during 
growth. Especially with the unique divisionpattern of Staphyloccocci where a 90° angle 
to the latest division plane is determined (Wheeler et al., 2011). Maybe they alternate 
the division planes by an alternating localization of different SEDS proteins, but the 
fundamental process behind this as well as choosing and maintaining a specific shape 
is not understood. Of course adaption to the habitat and survival strategies will have a 
lot of influence but this cannot be the only determination factor since different bacterial 
species with different shapes are known to in the same environment. Maybe there is 
something more crucial behind the shape of bacteria. 
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9 OUTLOOK 
9.1 FUNCTIONAL ASSAY FOR A FLIPPASE 
 
It should be testified that this RodA protein of S. carnosus is a functional flippase and 
that its substrate is indeed Lipid II. A biochemical evidence of its functionality for 
translocation of lipid-linked peptidoglycan precursors would solidify the role of rodA 
during peptidoglycan biosynthesis (Mohammadi et al., 2011).  
A possible experiment was performed first by Mohammadi et al. in 2014 by using NBD-
labelled Lipid II as a donor and tetramethylrhodamine cadaverine (TMR)-labelled 
vancomycin as an acceptor to generate a strong FRET (fluorescence resonance 
energy transfer) signal. Here, a potential flippase, FtsW, was overexpressed 
transgenically in E. coli and membrane vesicles were prepared. NBD-labelling on the 
outer leaflet could be quenched. So FRET signal could only be detected if a 
translocation from the inner to the outer leaflet has occurred. The labeled vancomycin 
specifically binds Lipid II (Breukink and de Kruijff, 2006). The overexpression of the 
target gene increased the FRET signal. The overexpression of control proteins (all of 
them integral membrane proteins) could not increase the signal. 
Using this already established method should allow showing whether or not RodA is a 
functional flippase in S. carnosus. The same test has to be applied to both FtsW 
proteins. 
9.2 SELECTIVE FLIPPING 
With an established assay to test the functionality of flippases it would be a step 
forward to analyze how specific the flip-flop mechanism works by altering the Lipid II 
substrate with different amino acids. As it is known that there are a variety of different 
Lipid II molecules containing different amino acids in the stem-peptide we would see 
which structures are tolerable and which are not anymore. Also the sugar backbone 
could be modified as other flippases such as the MPD translocator in eukaryotic cells 
is able to flip lipids containing Mannose-phosphate-dolichol (Sanyal and Menon, 2010). 
For this we would need to modify the in vitro biosynthesis of peptidoglycan (Vinatier et 
al., 2009). As a start the terminal amino acids could be exchanged as these are 
modifications already found in nature. This assay can also be used to test the substrate 
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specifity of the different PBPs and maybe antibiotics that target Lipid II or the reaction 
catalysed by the PBPs transglycolisation and transpeptidation (Bertsche, U. et al., 
2005) 
9.3 CROSS COMPLEMENTATION 
Complementation of the rodA mutant of S. carnosus could be tested with the RodA 
proteins of pathogenic staphylococcal species such as S. aureus and S. epidermidis. 
This will help to understand if the mechanism for growth and division is universal in 
staphylococci or if the there is something special about the S. carnosus rodA.  
 
9.4 STRUCTURE DETERMINATION 
The real structure of the muropeptides especially regarding where serine can be 
incorporated would help to understand the background of some of these 
missfunctioning processes that occur in the ∆ rodA mutant.  To solve these structures 
tandem mass spectrometry (MS-MS) analyses have to be performed. With the right 
set up it is possible to get a mass accuracy necessary to distinguish peptide elemental 
compositions (Clauser et al., 1999). But so far the set-up was not optimal and until now 
the performance of a direct LC-MS of the whole muropeptdie patterm was not possible 
due to unfavorable buffer conditions. High salt buffers will increase the background 
signal in the MS or the LC separation suffers from the infavorable MS buffer e.g. 
 
9.5 ROLE OF THE L,D-CARBOXYPEPTIDASE 
One point which comes fast to the mind is the deletion of this L,D-carboxypeptidase in 
S. carnosus and the MS-analysis of the S. pseudointermedies peptidoglycan regarding 
an accumulation of muropeptides with only three amino acids in the stem peptide. The 
same is true for the localization of this enzyme especially if the localization is altered 
in the ∆rodA mutant. 
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